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A computational method to model the steric zipper of amyloid fibrils (FibPreditor) is 
developed. The method generates an ensemble of structures for the steric zipper by a 
number of geometric operations and presents the most energetically favorable candidates 
as models of steric zipper. The method is shown to successfully reproduce a number of 
experimentally determined fibril structures.   
FibPredictor is then applied to model the steric zipper of glucagon fibrils. Phosphate ester 
derivatives of glucagon are designed based on these models as soluble and stable 
prodrugs or active alternatives for glucagon.  
A number of penta-peptide chaperones are also designed as excipients to delay glucagon 
fibrillation. Although penta-peptides can delay glucagon fibrillation, they are less 









CHAPTER 1. INTRODUCTION 
1.1 Computational Modelling of Amyloid Fibrils 
Amyloid fibrils have been associated with many important pathological conditions such 
as Alzheimer’s disease and type II diabetes. Amyloid fibrils also pose an important 
challenge in peptide and protein drug delivery as a major degradation pathway and have 
gained importance as bio-nanotubular scaffolds and triggerable drug delivery platforms 1–
6. The rational design of drugs that inhibit fibrillation, the design of stable formulations of 
peptide and protein drugs and the development of bio-nanotechnological fibril devices all 
depend on understanding the structure of amyloid fibrils1. However, experimental 
amyloid fibril structure determination is difficult 7. Computational method thus are 
specifically useful to predict the structure of amyloid fibrils and study their dynamics and 
energetics8.  
There have been a few successful attempts to generate de novo computational models for 
some specific amyloid fibrils 9–11, many computational studies on the mechanisms of 
fibril formation8, and many methods to predict aggregation-prone regions and amyloid 
forming sequences8,12–14.  Nonetheless, a method for modelling any class of amyloid 
fibrils starting from its sequence has been lacking until now. In this dissertation, a 
computationally fast and general computational procedure, FibPredictor, is proposed to 





1.2 Glucagon Fibrillation 
Glucagon is a 29-residue peptide hormone secreted by pancreatic α-cells which plays an 
important role in glucose metabolism. Currently, it is used for the emergency treatment of 
hypoglycemia and as a muscle relaxant for endoscopy procedures 15. Due to poor water 
solubility of this peptide in neutral pH it has to be solubilized in acidic pH. However, it is 
not stable even in acidic solution and comes out of solution forming irreversible, 
insoluble amyloid fibrils. Amyloid fibrils are highly stable protein constructs formed by 
long β-sheets known as β-spines which interact side-by-side by entanglement of their side 
chains forming a “steric zipper” 16,17.  
Glucagon amyloid fibrils formation compromises the potency of drug, generates toxic 
effects and increases solution viscosity which causes difficulty in delivering the 
formulation using an infusion pump or injection pen 15. Because of these solubility issues, 
glucagon is currently formulated as a lyophilized powder that is reconstituted just prior to 
administration, and any leftover solution is discarded immediately 18. The inconvenience 
and the risk of needle exposure and dosing error associated with the current formulation 
has led to underutilization of glucagon despite its safety and efficacy for treatment of 
insulin-induced hypoglycemia 18. Moreover, glucagon solubility issues has hindered 
development of closed loop artificial pancreas device. An artificial closed loop pancreas 
device can administer insulin and glucagon automatically in response to fluctuations in 
blood glucose and can significantly improve quality of life for insulin dependent diabetic 
patients 15. It is impractical to use the lyophilized formulation for an artificial pancreas, 
which requires that an adjustable amount of glucagon solution be administered 





glucagon as stable solution not only promotes its utilization for the current uses but also 
is a major step for expanding glucagon’s therapeutic benefits. Nonetheless, in spite of 
many attempts to solubilize glucagon and inhibit glucagon fibrillation such as modifying 
glucagon’s chemical structure 19,20, controlling solution conditions (e.g., pH, ionic 
strength) 21–24 and using stabilizing additives (e.g., cyclodextrins) 25, to date a stable 
solution formulation of glucagon is not yet available in clinic.  
Stable phosphorylated glucagon derivatives are introduced in this dissertation as pro-
drugs or active alternatives to glucagon which are soluble in neutral pH and do not show 
any fibrillation for at least for one month. Penta-peptide chaperones are also tested as an 
alternative method to delay glucagon fibrillation. 
1.3 Outline 
Chapter 2 presents penta-peptide chaperones to delay glucagon fibrillation. Although 
penta-peptides delay glucagon fibrillation, their effects are limited compared to 
alternative approaches, such as the one presented in chapter 5. Chapter 3 presents a 
number of statistical potentials for protein structure prediction. One of these statistical 
potentials is then used in the software presented in chapter 4. Chapter 4, presents a 
computational method for modelling the steric zipper of amyloid fibrils. This 
computational method is applied in chapter 5 to design phosphate ester derivatives of 
glucagon as stable and soluble pro-drugs or active alternatives to glucagon.  
I have performed the computational studies in Dr. Markus A. Lill’s lab, and the 





CHAPTER 2.  PENTAPEPTIDE CHAPERONES TO INHIBIT GLUCAGON 
FIBRILLATION 
2.1 Introduction 
This chapter presents small peptide chaperones, to inhibit glucagon fibrillation. Small 
peptides have previously used in other cases of problematic amyloid β-fibrils and a 
number of natural and non-natural peptides have been shown to successfully inhibit 
fibrillation 26–29. We go in the same direction and design small peptide chaperones to 
inhibit glucagon fibrillation. Due to the particular restrictions in case of glucagon such as 
high hydrophobicity and unavailability of the atomic structure for the fibril, we use a 
design approach which differs from that of our predecessors. The peptides introduced in 
this paper, successfully delayed glucagon fibrillation in spite of their simple structure and 
small size. These peptides provide a starting point for further investigation of small 
peptide chaperones for inhibiting β-fibril formation. 
 
2.2 Materials and methods 
2.2.1 Peptide design 
A few natural and non-natural small peptide chaperones have shown to inhibit β-fibril 
formation in Alzheimer amyloidosis. The natural peptides were designed using the 
hydrophobic fragment of the target fibrillating protein as template. Proline residues were 





 their special geometric and hydrogen bonding characteristics 26–28. Although this design 
approach is shown to be successful in other cases, it cannot be used to design peptides to 
inhibit fibrillation of our target, glucagon. Glucagon hydrophobic region is too 
hydrophobic and not soluble at all. Incorporation of proline residues would only 
aggravate this water insolubility resulting in insoluble peptide chaperones. The rational 
structure-based design approach applied in case of previous non-natural peptides that 
inhibit fibrillation is also not possible in the case of glucagon. Those non-natural peptides 
were designed specifically to interact with the steric zipper region of their target fibrils 
and prohibition of zipper formation inhibited fibrillation in those cases 29. This design 
approach depends on availability of atomistic details of the zipper structure which is not 
at hand for glucagon. Due to the challenges of β-fibril structure determination, a three-
dimensional atomistic structure of glucagon fibril is not yet available 7,30.  
Since the template-based and structure-based design approaches were not possible in case 
of glucagon, we aimed at global screening of peptides for their ability to interfere with 
glucagon fibrillation. In order to limit the screening set, we focused on penta-peptides, 
the shortest natural peptides with known fibrillation-inhibition properties 26. However, 
even for penta-peptides, there are 205 = 3,200,000 candidates, and a comprehensive 
screening was impractical. Fractional factorial design was used to design a small set of 
peptides covering the whole penta-peptide space. Fractional factorial design approach has 
previously used for designing small but information-rich sets of peptides 31,32 and 
theoretically, a set designed in this way provides a fast and cheap way to screen the 





Two numerical descriptors for amino acids (tciz1 and tciz2) introduced by Muthas et al 32 
were used. The two descriptors are the first two principle components of a number of 
different descriptors for amino acids. These two descriptors  have been shown to capture 
most of the variance in peptide sets and are calculated for many natural and unnatural 
amino acids 32. There are two sets of these variables, one calculated based on only amino 
acids, the other calculated based on a larger set of natural, unnatural and derivatized 
amino acids 32. The latter set was used due to its larger scope and extendibility to 
unnatural amino acids in later studies.  
Describing each amino acid with two descriptors, each penta-peptide was described with 
ten residue-position-specific variables (table 1). A 210-6 fractional factorial design table 
was used (obtained from 33) (table 1). This fractional factorial design table assumes two 
levels for each descriptor, and hence the values for the descriptors should be discretized 
in two levels. As the current study was focused on natural peptides, the positivity or 
negativity of the variable calculated based on both natural and unnatural amino acids 
could not be used for discretizing the values into two levels. Therefore, the average value 
of the tciz1 and tciz2 for natural amino acids was set as the zero point and all the 
descriptors were transformed accordingly. The negativity and positivity of the 
transformed values was the criteria to discretize the variables in two levels: positive or 
negative.  
Having two descriptors each with two discretized levels, amino acids were categorized 
into four classes: positive-positive, negative-positive, positive-negative and negative-
positive (table 2). Representative amino acids were chosen to represent each category 





shown to be important in glucagon fibrillation in our MD simulation studies 34 and thus, 
were chosen to represent their corresponding categories. H was chosen for the (positive-
positive) class as it can participate in various types of interactions and its interaction 
versatility may facilitate the peptide-glucagon interaction. 
Substituting the representative amino acids in table 1, we obtained our set of peptides 
(Table 3). From the sixteen peptides of this set, H6 and H11 were excluded due to their 
very high insolubility which interferes with the experiments. 
 
2.2.2 Sample Preparation 
 
Glucagon at 1.6 mg/mL in 3.2 mM HCl, 0.9% NaCl (w/v) (pH 2.5) was centrifuged at 
14,000 rpm for 5 min and filtered through 0.1 μm filters to eliminate any insoluble 
particles. For water-soluble peptides (h1, h3, h4, h8, h9, h10, h12, h13, h14, h15 and 
h16), 100 μL of the filtered glucagon sample was quickly transferred to a 96-well black 
flat bottom microtiter plate in duplicate or triplicate depending on peptide availability and 
incubated with 40 μL of 10 mg/ml solution of peptide in buffer and 50 μM ThT final 
concentration. For peptides with less water-solubility (h2, h5, h7), 10 μL of 40 mg/ml 
solution of peptide in DMSO was used. The final volume was adjusted to 200 μL using 
the buffer as mentioned above. Two control triplicates of glucagon and ThT without 
peptide, one without and the other with 10 μL DMSO were also prepared as standards. 
Samples of peptides with ThT but without glucagon were also prepared as negative 
controls as described above. Buffer was used to adjust the final volume of the control 





measurements were carried out in a BioTek Synergy 4 Multi-Detection microplate reader 
(BioTek Instruments, Winooski, VT) as described below. 
 
2.2.3 ThT Assay 
 
The fluorescence intensity of ThT was measured over 24 hours every 15 minutes at 23°C 
with 5 s automixing before each reading with the excitation and emission wavelengths set 
to 440 nm and 482 nm. Fluorescence signals exceeding 100,000 (overflow) were re-set to 
100,000 for graphing purposes. 
 
2.2.4 Intrinsic Fluorescence Assay 
 
The excitation and emission wavelengths were set to 295 nm and 355 nm, respectively, to 
look at the fluorescence of Trp25. Peptides do not have tryptophan in their sequence and 
therefore do not interfere with glucagon signal. Measurement was carried out for 24 h at 
23°C at 15-min intervals preceded by 5 s automixing before each reading. Very high 
fluorescence signals exceeding 100,000 (overflow) were re-set to 100,000 for graphing 
purposes. 
 
2.2.5 Partial Least Square Regression 
 
Partial least square regression (PLSR) is a common linear modelling technique for QSAR 





reliable models with numerous collinear and noisy variables. In this method, latent 
independent and dependent factors are constructed aiming at maximizing correlation 
between the variations of the independent and dependent ones 35. 
2.2.6 MD Simulations 
Initial structures of the N-terminal (residues 1–8) and C-terminal (residues 22–29) 
fragments were generated from reported NMR structures of glucagon (Protein Data Bank 
(PDB) ID: 1KX6)36. Three different models were selected as starting configurations for 
MD simulations, and are referred to as models 1, 5, and 10 in keeping with the 
numbering in the ensemble of NMR models in the original PDB file. In simulations of the 
interactions of two molecules of either the 1–8 fragment or the 22–29 fragment, the 
molecules were initially placed close to one another with arbitrary relative initial 
orientation, maintaining at least a 4 Å distance between any two atoms in the two 
fragments. Combining the conformations of the three NMR models for each fragment, 
three starting configurations were generated for each of the N-terminal and C-terminal 
fragment simulations. Specifically, starting configurations for both the N-terminal 
fragment (1, 2, 3, 4, 5, 6, 7 and 8) and the C-terminal fragment (22, 23, 24, 25, 26, 27, 
28 and 29) simulations were: model 1 with model 5, model 1 with model 10, and model 5 
with model 10. All simulations were performed on capped peptides (i.e., N-terminus 
acetylated and C-terminus amidated) and the side chains of His residues in the N-terminal 
fragments were doubly protonated to represent the most likely state in solution at pH 2.5. 
To simulate the interactions of peptide fragments, the molecules were solvated in a 
preequilibrated octahedron of TIP3P water molecules, with a minimum distance of 10 Å 






performed in an NPT ensemble using the AMBER-99SB force field with periodic 
boundary conditions and an integration time step of 2 fs, applying the particle mesh 
Ewald method to treat electrostatic interactions38. All bonds involving hydrogen atoms 
were constrained using the SHAKE algorithm 39 and van der Waals interactions were 
truncated at a distance of 10 Å. A Langevin thermostat 40 with collision frequency of 1 
ps−1 was used to maintain the temperature at 298 K, and pressure was maintained at 1 atm 
using isotropic position scaling with a pressure relaxation time of 2 ps. The N-terminal 1–
8 fragment simulation was neutralized by the addition of one Cl− ion per fragment. In a 
simulation, the water molecules with constrained peptide(s) first were energy minimized. 
The system was then gradually heated from 0 K to 298 K over a 20 ps MD simulation 
period. The system was then equilibrated at constant temperature and pressure for 200 ps 
and final production runs performed for 100 ns. Snapshots were saved every 0.05 ns, 
resulting in 2000 snapshots for each production simulation. 
A contact between residues from two molecules was identified if a distance <5 Å was 
observed between any pair of atoms. Only contacts formed between two different peptide 
molecules were analyzed, and not those within a single strand. All MD snapshots of the 
simulations were considered for contact analysis. The frequencies of observing contacts 
were first analyzed for the three separate simulations of two molecules, and then 
averaged over all three simulations to obtain a single mean contact frequency. The α-
helix content of each snapshot was analyzed using the DSSP software 41,42. In simulations 
of two interacting peptides, snapshots were analyzed separately for each peptide. For 
each amino acid, the percentage of snapshots in which it was part of an α-helix 






various single and two peptide molecule(s) simulations was computed. Molecules were 
visualized in PyMOL 43–45 and the graphs were generated using Python and matplotlib 46. 
2.3 Results 
2.3.1 Glucagon interactions by MD simulation 
MD simulations were performed to provide insight into structural changes and early 
interactions involved in glucagon fibrillation. The α-helix content of fragment 1–8 was 
negligible in simulations of either one or two molecules, the latter allowing for effects of 
interaction on secondary structure (Figure 1, A and B). In contrast, the C-terminal 
fragment 22–29 formed α-helices in both one- and two-molecule simulations (Figure 2, C 
and D), with greater α-helix content in simulations of two molecules. To mimic the 
experimental conditions, MD simulations were repeated in the presence of 0.9% NaCl for 
a system containing two N-terminal fragments (model 1 with model 10) and two C-
terminal fragments (model 1 with model 10). The simulations were performed for 15 ns 
and compared to the first 15 ns of the salt-free simulations. Though a slight increase in 
secondary structure was observed in the presence of salt, the difference in the α-helix 
content was minimal (data not shown). 
In light of the experimental evidence that C-terminal interactions are involved in the early 
stages of fibrillation34, we aimed to identify the critical contacts for the C-C-terminal 
interactions. When analyzing the contacts between amino acids, the C-terminal fragment 
22–29 showed at least one contact in >94% of snapshots for all models tested. To 
highlight the preferred side-chain interactions, the 10 most frequently observed contacts 
averaged from three independent simulations of two molecules of the C-terminal 






acids are most frequently observed and account for eight of the 10 most frequent 
interactions. In particular, Trp-25 participates in four of the 10 most frequent interactions, 
i.e., with Phe-22, Val-23, Leu-26, and Met-27. Amino acids adjacent to Trp-25 also 
participated in hydrophobic contacts. Phe-22, for example, is engaged in five out of the 
top 10 most frequent interactions, four with hydrophobic or aromatic residues. An 








Figure 1 Simulations  of  α-helix  content  of  glucagon-derived  peptides:  (A)  a  single 
molecule  of  fragment  1-8,  (B)  two  molecules  of  fragment  1-8,  (C)  a  single  
molecule  of fragment 22-29 and (D) two molecules of fragment 22-29. The α-helix 















Figure 2 Identification of critical contacts for the C-terminal interactions in glucagon 
fibrillation under acidic conditions. The 10 most frequent contacts observed in 
simulations of two molecules of glucagon fragment 22–29 are shown. Each line 
represents one of the 10 interactions, which are ordered from red to blue based on 
frequency. The amino acid residues are indicated by their single letter code with residue 









2.3.2 Glucagon Fibrillation 
The ThT fluorescence signal increases upon interaction of ThT molecules with an 
amyloid β-fibril and allows following fibrillation. Tryptophan fluorescence signal drops 
as tryptophan residues get buried upon peptide aggregation and thus, provides a second 
complementary method to conform ThT results 34. ThT and tryptophan intrinsic 
fluorescence of glucagon were followed over 24 hours in presence and absence of each 
peptide, in order to investigate the fibrillation inhibitory effects of the peptide set. 
ThT fluorescence graphs (Figure 3) show that glucagon fibrillation starts with a lag time 
followed by a sudden log phase and ends reaching a plateau. This is a known pattern and 
is previously reported and explained by us and others 34,47. This pattern shows that once 
the fibrillation passes the lag time, it fast goes to completion. Any effort to stop or reverse 
the fibrillation is better to be focused on elongation of the lag time. Tryptophan 
fluorescence graphs (Figure 1), although less clearly, show a general pattern similar to 
ThT: a lag time and a sudden drop indicating a fast aggregation. However, the tryptophan 
fluorescence patterns are less clear and definitive compared to ThT fluorescence graphs. 
Nonetheless, the sudden drop in the tryptophan fluorescence, if identifiable, happens 
usually close to the time that ThT fluorescence surges and verifies the lag time identified 
by ThT fluorescence.  
Although the lag time-log phase-plateau pattern is generally preserved across DMSO- 
and water-soluble peptides, the shape of the graphs are slightly different between these 
two groups. The difference is most salient in the standard glucagon samples with no 
peptide, where the DMSO containing standard show a less definitive plateau compared to 






shorter in presence of DMSO compared to the no DMSO standard sample. This indicates 
that DMSO interferes with the fibrillation process and make it slightly faster. None of the 
peptides show fibrillation of their own (graphs not shown) and the glucagon containing 
samples were the only ones which showed fibrillation. 
Although the general patterns of ThT and tryptophan fluorescence graphs were preserved 
in presence or absence of peptides, the lag time varied significantly in presence of 
peptides as discussed in detail in the next section. 
2.3.3 Fibrillation lag time extension 
Figure 4 shows the lag time difference between the standard glucagon without any 
peptide and glucagon in presence of each of the peptides. All of the peptides studied 
affected the fibrillation lag time and except H7, all of them elongated the lag time. The 
most effective peptide H8 (QFFTQ) elongated the fibrillation lag time for more than 700 
minutes resulting in a total lag time of nearly 1000 minutes. H8 is water soluble and its 
solubility in addition to its effectiveness make it a promising hit for glucagon fibrillation 
inhibition. 
There is considerable variation between the effects of different peptides on the fibrillation 
lag time. This variation shows the lag time elongations are not due to general presence of 
any peptide, but are in fact the sequence-specific. Note that the sequence of these 
peptides are composed of only four different residues and the variation between the 
sequences is very limited. Nonetheless, even this limited sequence variety results in 
considerable divergence in fibrillation inhibitory effects. Variation in inhibitory effects of 














Figure 3 ThT and Tryptophan fluorescence over time. The dotted y=4000 line indicates 






























Figure 4 The glucagon fibrillation lag time difference between the samples containing 
various peptides and the standard no-peptide samples. Bars related to water soluble and 
DMSO soluble peptides are colored in grey and white respectively. Water soluble and 








Figure 5 Root mean squared error of the predicted lag time differences with experimental 





































2.3.4 PLS model 
Figure 5 shows the root mean squared error between the predicted lag time differences 
with standard and the experimental measurement (rmsep) vs the number of latent 
independent factors included in the PLS model. The figure shows improvement in rmsep 
up to three factors. Figure 6 shows the predicted lag time difference with standard vs the 
measured values for the PLS model with three latent factors. Based on these results the 
PLS model with three latent factors was used to predict the lag time difference with 
standard for all possible penta-peptides. The results are shows in Figure 7. According to 
these predictions, there are many candidate penta-peptides that can delay fibrillation, and 
the study suggests hit penta-peptides, such as QFFTQ. However, the maximum delay will 
be limited to around two thousand minutes (≈33 hours) which is not enough for practical 
uses of glucagon.  
2.4 Conclusions 
Protein aggregation poses an important challenge for therapeutic formulation of proteins 
48. Glucagon fibrillation is an example where the therapeutic benefits of a peptide drug is 
significantly limited by low stability of its formulation. Many attempts to stabilize 
glucagon have not yet resulted in its soluble formulation in clinic. This studies the 
potential of small peptide chaperones, more specifically penta-peptides, to inhibit 
glucagon fibrillation. We also suggested a hit penta-peptide sequence: QFFTQ. The 
fibrillation inhibitory effects of these peptides is sequence-specific. This opens a path 
towards developing more effective and more potent glucagon fibrillation peptide 






to solve glucagon formulation problem. Other paths (such as the chemical modification 
of glucagon presented in the next chapters) should be pursued.  
The methods and the results presented in this paper have implications even beyond 
glucagon fibrillation. Amyloid β-fibrils are involved in many serious pathological 
conditions and are important drug targets 49. The present work and its predecessors show 
that small peptide chaperones have the potential to successfully inhibit amyloid β-
fibrillation and underscore the importance of small peptide chaperones for drug 
development. However, peptide drug design is challenging due to the combinatorially 
large number of candidate sequences. The peptide design approach used in this study can 






Table 1 210-6 fractional factorial design table; each row corresponds to one peptide 
Amino acid 1  Amino acid 2 Amino acid 3 Amino acid 4 Amino acid 5 
tciz1 tciz2  tciz1 tciz2 tciz1 tciz2 tciz1 tciz2 tciz1 tciz2 
-1 -1  -1 -1 -1 -1 -1 -1 +1 +1 
+1 -1  -1 -1 +1 -1 +1 +1 -1 -1 
-1 +1  -1 -1 +1 +1 -1 +1 -1 -1 
+1 +1  -1 -1 -1 +1 +1 -1 +1 +1 
-1 -1  +1 -1 +1 +1 +1 -1 -1 +1 
+1 -1  +1 -1 -1 +1 -1 +1 +1 -1 
-1 +1  +1 -1 -1 -1 +1 +1 +1 -1 
+1 +1  +1 -1 +1 -1 -1 -1 -1 +1 
-1 -1  -1 +1 -1 +1 +1 +1 -1 +1 
+1 -1  -1 +1 +1 +1 -1 -1 +1 -1 
-1 +1  -1 +1 +1 -1 +1 -1 +1 -1 
+1 +1  -1 +1 -1 -1 -1 +1 -1 +1 
-1 -1  +1 +1 +1 -1 -1 +1 +1 +1 
+1 -1  +1 +1 -1 -1 +1 -1 -1 -1 
-1 +1  +1 +1 -1 +1 -1 -1 -1 -1 













Table 2 Four classes of amino acids based on the two-level discretization of tciz1 and 
tciz2 variables. 
tciz1  tciz2  Amino acids 
-1 -1 A, T, S, C 
+1 -1 V, L, I, M, F, 
W 
-1 +1 N, D, Q, E 
























Table 3 training set; each row corresponds to one peptide 
Peptide code aa 1 aa2 aa3 aa4 aa5 
H1 T T T T H 
H2 F T F H T 
H3 Q T H Q T 
H4 H T Q F H 
H5 T F H F Q 
H6 F F Q Q F 
H7 Q F T H F 
H8 H F F T Q 
H9 T Q Q H Q 
H10 F Q H T F 
H11 Q Q F F F 
H12 H Q T Q Q 
H13 T H F Q H 
H14 F H T F T 
H15 Q H Q T T 







CHAPTER 3. ARE DISTANCE-DEPENDENT STATISTICAL POTENTIALS 
CONSIDERING THREE INTERACTING BODIES SUPERIOR TO TWO-BODY 
STATISTICAL POTENTIALS FOR PROTEIN STRUCTURE PREDICTION? 
3.1 Introduction 
Protein structure prediction still represents a significant challenge to computational 
biophysics. Recently developed statistical scoring functions have proven to be a valuable 
tool for identification of the native structure among a typically large set of candidate 
structures 50,51. These potentials are typically based on the assumption that the total free 
energy of a protein structure can be computed by the sum of all pairwise free energies 
(∆𝐺(𝑟𝑖𝑗))  
 
 ∆𝐺𝑡𝑜𝑡 = ∑ ∆𝐺(𝑟𝑖𝑗)
𝑖<𝑗
 Eq. 1  
 
where i and j are either interacting bodies e.g. individual atoms of the protein or 
representative points for each amino acid, e.g. the Cα atom etc. The pairwise free 
energies are often calculated based on the pairwise distribution function (P(rij)) between a 
specific pair of atom types or amino acids, i and j  













where Z is the partition function, R is the gas constant and T is the temperature. 
Therefore, the inverse Boltzmann equation used to calculate ∆𝐺(𝑟𝑖𝑗) would be:  
  
 ∆𝐺(𝑟𝑖𝑗) = −𝑅𝑇 𝑙𝑛 𝑃(𝑟𝑖𝑗) − 𝑅𝑇 𝑙𝑛 𝑍 Eq. 3  
 
Typically ∆𝐺(rij)  (the potential of mean force (PMF)) is computed with respect to a 
reference state R representing a hypothetical system with uniform and unbiased 
interactions between the different atom types or amino acids. The relative free energy 
between a pair of atoms or residues i and j with respect to this reference state is then 
computed by   






 Eq. 4  
 
The pairwise distribution function can be computed by measuring the frequency of pairs 
of atom types at a given distance using databases of experimentally solved protein 
structures 52. An early example of such potential functions is developed by Samudrala 
and Moult. Their function models potentials of atomistic interactions based on the 
pairwise distance between two interacting bodies 51.  
The underlying assumption of Eq. 1, that the total free energy of a protein structure can 
be computed by the sum of all pairwise free energies, however, is not physically justified. 
More precisely, the exact free energy of a system is determined by the statistical 






 ∆G(r1, … , rN) =  −kBT ln P(r1, … , rN) − kBT ln Z  Eq. 5  
 
      Thus Eq. 1 neglects correlation effects between multiple atoms or amino acids in a 
protein. In order to model these higher order interactions a number of multi-body contact 
based statistical potentials have been developed. Most of these statistical potentials are 
based on Delauney tessellation - a geometric technique to identify the neighboring bodies  
53–57, although some other geometric approaches have also been investigated  58. To the 
best of our knowledge none of these multi-body potentials look into the details of 
distance between interacting residues. Also they usually use very coarse-grained 
representations of interactions e.g. interaction between residues and do not model 
interactions between various atom types. Based on this discussion, we asked the question 
if we can model details of three-body interactions using distance dependencies between 
pairs of pairwise interactions between atomistic interacting bodies. More precisely we 
hypothesized that considering the presence of a third body adds valuable information to 
statistical potentials based on interaction pairs. This additional information of multi-body 
interactions may improve the scoring process and consequently the identification of 
native protein structures.  
      The importance of three-body terms in determining the stability of globular forms of 
polymers has been established long ago, and by analogy their inclusion in statistical 
potentials for protein native structure detection has been conjectured 59.  The importance 
of multi-body interactions in protein folding has been shown independently using other 
computational methods 57,60, which makes the idea of building a multi-body distance-






In this study, we generated a distance-based quasi-three-body statistical potential for 
atom-based interacting bodies and analyzed if we can identify dependence between 
multiple pair-wise interactions. We investigated the effect of the distance from a third 
body on the pairwise distance of two interacting partners. 
     We developed statistical potentials describing the simultaneous interaction of three 
bodies that represent important physical elements of the protein and used it to 
differentiate native protein structures from decoys. Those elements characterize either 
physicochemical properties of the protein, which we call the physicochemical elements 
throughout the paper (hydrogen-bond acceptors and donors, negatively and positively 
charged, hydrophobic, and aromatic groups), Amber atom types, or amino acid Cα atoms. 
We assumed that the presence of the third interacting element affects the pairwise 
distribution function of the other two interacting elements by altering the energetically 
optimal distance between the two interacting bodies. We also used three simple counting 
scoring functions (counting hydrophobic centers or Cα's within a certain distance from 
each other and counting the number of hydrogen bonds) in order to investigate if using 
more sophisticated and computationally costly methods perform better compared to very 
simplistic approaches.  
In order to assess the performance of different scoring functions, we tested the functions’ 
ability to separate decoys from native protein structures.  Three different decoy sets were 
utilized to evaluate the performance of the scoring functions for protein structure 
prediction 61. The performances of our quasi-three-body scoring functions were compared 







3.2 Materials and Methods 
3.2.1 Assigning the properties to proteins 
Statistical potentials were derived between different elements characterizing the 
physicochemical and structural properties of a protein structure. Physicochemical 
properties of a protein were defined as hydrophobic (H), hydrogen-bond donor (D), 
acceptor (A), and aromatic (R) properties and formally charged functional groups (P for 
positively charged, N for negatively charged,). For a given protein, the physicochemical 
elements were assigned as follows: Hydrophobic elements were assigned to carbon and 
sulfur atoms that are not bonded to an oxygen or nitrogen atom. For assigning hydrogen 
bond donors and acceptors, hydrogen atoms were added to the protein structure using 
Open Babel 2.3.1. Hydrogen bond acceptor and donor physicochemical elements were 
included in the generation of statistical potentials only if they form intra-protein hydrogen 
bonds, discarding unpaired hydrogen bonds. The following criteria were used to define 
hydrogen bonds: The distance between a donor group and the acceptor atom must be 
closer than 4.6 Å, the angle between donor heavy atom, donor hydrogen and the acceptor 
heavy atom needs to be in the range 120-180°, and the angle between acceptor lone-pair, 
acceptor heavy atom and the donor hydrogen must be smaller than 45°. Acceptor and 
donor elements were then assigned to the acceptor and donor heavy atoms. It should be 
noted that although only acceptor or donor groups that are engaged in hydrogen bonds are 
considered in the analysis, triplets can freely contain one partner independent of the other 
as well as both partners.  An aromatic physicochemical element was assigned to the 
center of each aromatic ring, i.e. to the side chains of Phe, Tyr, His and Trp. Negatively 






Lys specific side chain atoms.  Scoring functions constructed from physicochemical 
elements are denoted by “Phys_” in their names. We also generated statistical scoring 
functions based on analyzing quasi-three-body and two-body interactions using all heavy 
atoms classified by Amber99 atom types. These scoring functions are denoted by 
“Amb_”. Two additional scoring functions are based on quasi-three-body and two-body 
interactions among the Cα atoms of all residues; no classification with respect to amino 
acid attributes was used. These scoring functions are denoted by “Ca_”. Throughout this 
paper we call the scoring functions resulting from the quasi-three-body approach as 
quasi-three-body scoring functions (denoted by the suffix “_3b_score”) to differentiate 
them from the two-body scoring functions (denoted by suffix “_2b_score”) resulting from 
pair-wise distance distributions. Physicochemical elements, Amber atom types and amino 
acid Cα atoms were assigned using in-house software. 
3.2.2 Protein database for generation of statistical potential 
To generate the statistical potentials, 1000 non-redundant protein structures were chosen 
from the PDB databank by clustering proteins into groups based on their pairwise 
sequence similarity and picking a representative from each group using the online tool 
VAST.  
3.2.3 Interacting Pairs and Triplets 
For each set of properties (physicochemical elements, Amber atom types and Cα atoms) 
pair-wise and quasi-three-body statistical potentials were derived for all possible 
combinations of properties. For pair-wise potentials the frequency of each pair of 
properties A and B as a function of distance is stored in histograms (𝐹𝑖
𝐴𝐵) where i 






Å are considered in our analysis. Throughout the paper, parentheses around vectors and 
matrices like those around (𝐹𝑖
𝐴𝐵) refers to the vector or matrix as a whole, and lack of 
these parentheses denotes an element in that vector or matrix 
For quasi-three-body interactions, we extend pair-wise statistical potentials to triplets of 
interacting properties using a novel geometric approach. The three distances AB, AC, and 
BC unambiguously describe the relationship of the triplet of interacting elements A, B, 
and C (Fig. 8-B). The corresponding histogram would require for each triplet of 
properties data sampling for 323=32,768 bins (32 bins per distance).  Obtaining sufficient 
experimental data for such a large number of bins is impractical. To address this 
sampling problem, we reduced the dimensionality of the triplet by reducing the 
description of triplet interactions to two distances spawning from a center point (Fig. 1-
A). As a consequence, three different pairs of distances (Fig.8-A) with different center 
element can be formed which constitute different statistical potentials, i.e.  (AB, BC) with 
center B, (BA, AC) with center A, (AC, CB) with center C. Therefore each triplet is 
defined by its center and the two other elements (Fig. 8-A). Consequently, the full three-
body statistical potential is reduced to two pairs of conditional pair-wise interactions, 
which we named quasi-three-body potentials throughout this study. 
Each of the properties is used as the center of the triplet, and all of the combinations of 
other properties that form triplets with this center are computed. For example, for six 
different physicochemical elements 126 triplets were formed. A two-dimensional 
distance matrix (𝐹𝑖𝑗
𝐴𝐵𝐶) for each triplet ABC (center: B) is computed with a distance 
range from 2.0 to 10 Å, and a bin size of 0.25 Å.  The bin number for distance AB and BC 
are i and j. (𝐹𝑅,𝑖𝑗






below. A vector (𝐹𝑖
𝐴𝐵) is used to store distance data in a similar way for two-body 
interactions. (𝐹𝑅,𝑖





𝐴𝐵) vectors and matrices of each triplet or pair are 





3.2.4 Statistical potential and definition of reference state 
The quasi-three-body and two-body statistical potentials are derived from the elements of 
the distance matrix 𝑃𝑖𝑗
𝐴𝐵𝐶  and vector 𝑃𝑖
𝐴𝐵  using Boltzmann inversion: 
 𝐵𝑖𝑗




𝐴𝐵𝐶 Eq. 6  
and  
 𝐵𝑖




𝐴𝐵 Eq. 7  
for interacting triplets and interacting pairs respectively. R is the gas constant, T is the 
temperature, and (𝐵𝑖𝑗
𝐴𝐵𝐶)  and (𝐵𝑖
𝐴𝐵) are matrices of the individual quasi-three- and two-
body interaction terms of a statistical potential. If 𝑃𝑅,𝑖𝑗
𝐴𝐵𝐶is equal to or less than 410-6 or if 
𝑃𝑅,𝑖
𝐴𝐵is equal to or less than 210-4, 𝐵𝑖𝑗
𝐴𝐵𝐶   or 𝐵𝑖
𝐴𝐵 are set to zero respectively in order to 
avoid artificially high values due to division by a value close to zero. 
A randomized state with no specific interactions between the protein-describing elements 
is generated to serve as reference state. In generating the random state we adopted a 
shuffling approach 62:  randomized state matrices (𝑃𝑅,𝑖𝑗
𝐴′𝐵′𝐶′
) are generated by assigning 
each triplet ABC from a protein structure with given distance bins i and j to the same 






aromatic triplet with distance bins i=6, j=15 will be assigned to the same distance bins 
i=6, j=15 in the random 𝑃𝑅,𝑖𝑗
𝐴′𝐵′𝐶′
 matrix where A’B’C’ might be any random triplet of 
properties such as acceptor, positively charged, hydrophobic, etc.. In this way, the 
random state matrices for different triplets preserve the shape and associated interaction 
distances of the proteins used in the analysis. As the reference state has a protein-like 
shape, the resulting scoring function will not be biased towards decoys solely by having a 
protein-like shape. Using an ideal gas to generate the random matrix would not remove 
the inherent shape and density dependency of the statistical potential from the protein 
shape.  In other words, the ideal gas reference state produces a random spherical 
distribution of properties, and all protein structures, native and decoy, would already vary 
significantly from this reference state due to having a protein-like shape. 
For the Ca_score scoring function, there is only one type of triplet or doublet which 
makes the use of the randomization method described above infeasible. In this scoring 
measure, for each protein, a 1 Å grid is overlaid onto the protein structure. The protein’s 
shape is reproduced by those grid points whose x, y and z coordinates of a grid point fall 
between the x, y and z coordinates of any two Cα's of the protein respectively. Then the 
same number of Cα atoms of a protein are randomly distributed onto those grid points 
that cover the shape of the protein with a minimum distance of 1.5 Å between any two 
Cα atoms. This distribution generates a pseudo protein corresponding to each protein 






3.2.5 Smoothed Potential 
smthd_Phys_2b and _3b potentials were generated by smoothing Phys_2b and _3b using 
a cubic spline. Every other bin was been used as a knot and the fitted cubic spline was 
then used to calculate the values for the other bins. 
3.2.6 Scoring 
The total scores result from the summation of sub-scores corresponding to all individual 
pairs or triplets in a protein: Matrices (𝐶𝑖𝑗
𝐴𝐵𝐶) or vectors (𝐶𝑖
𝐴𝐵) are constructed for each 
protein by counting the number of observations for each triplet ABC or pair AB in the 
distance interval corresponding to bin ij or bin i, respectively. The sub-score for each 
triplet ABC (SABC) or pair (SAB) is then calculated using the following formula: 
 𝑆𝐴𝐵𝐶 =  ∑(
𝐶𝑖𝑗






 Eq. 8  
and  







 Eq. 9  
𝑑𝑖 is the AB distance and 𝑑𝑗  is the BC distance in angstroms. Division by 𝑑𝑖
2 ∙  𝑑𝑗
2 and 𝑑𝑖
2 
normalizes the frequency of observing interacting bodies with respect to their distance 
from the central body of the triplet. The total quasi-three-body and two-body scores are 
then calculated by summing over all quasi-three-body or two-body sub-scores. 
3.2.7 Other scoring functions used for comparison 
To evaluate the performance of our statistical scoring functions for identifying the native 
protein structure, the following existing scoring functions and some simplistic counting 






3.2.7.1 Simple Counting Methods 
Two dominant interaction types are often considered to be main forces for the stability of 
proteins: the hydrophobic effect and hydrogen bonding  63. For comparison with our 
statistical scoring function, these two underlying forces are represented in two very 
simplistic counting methods to differentiate native structures from decoys. The number of 
hydrophobic atoms within 5 Ȧ distance of each other (count_Phob_score), and the 
number of hydrogen bonds formed (count_H_score), were considered. The final simple 
counting scoring function measures the compactness of the protein by counting the 
number of Cα’s within 5 Ȧ distance of each other Cα atom (count_Ca_score).  
3.2.7.2 Conventional Scoring Functions 
Four widely used scoring functions, DFIRE2, dDFIRE, GOAP, FoldX and Rosetta 
(called conventional scoring functions in this paper) are tested for comparison. Details of 
these scoring functions is as follows and more can be found in the cited references: 
FoldX: FoldX uses an empirical scoring function that calculates the free energy by linear 
combination of several empirical terms describing various energetic contributions to the 
stability of protein structures (e.g. van der Waals energy, hydrogen bond energy etc.): 
 
∆G = a.∆Gvdw + b.∆GsolvH + c.∆GsolvP + d.∆Gwb + e.∆GHbond 
+ f.∆Gel + g.∆Gkon + h.T∆Smc + k.T∆Ssc + l.∆Gclash                  
Eq. 10  
in which a, b,…,l are relative weights of different energies and T is temperature. ∆Gvdw 
represents van der Waals interactions and is calculated based on experimental data of 
vaporizing amino acids from water. ∆GsolvH and ∆GsolvP represent desolvation energies of 






on transferring amino acids from aqueous to organic solvents. ∆Gwb represents the energy 
of water molecules forming more than two hydrogen bonds with the protein. ∆GHbond 
represents hydrogen bonding energies and is computed based on data resulted from 
engineered double mutant cycles. ∆Gel is the electrostatic interaction energy and is 
computed using Coulomb’s law. ∆Gkon is an additional electrostatic component between 
atoms of different polypeptide chains. ∆Smc and ∆Ssc are entropic penalties for restraining 
the backbone and side chains in a certain conformation and is calculated based on results 
of statistical analyses on protein structures. ∆Gclash is a measure of the energy penalty 
associated with steric clashes between different atoms. 
FoldX can be used to investigate the destabilizing/stabilizing effects of point mutations 
on protein structure. The executable of FoldX (version 6.0) was downloaded from 
foldx.crg.es. 
Rosetta: Rosetta scoring function includes a combination of statistical and physical 
scoring terms. The terms of the scoring function include residue solvation, residue pair 
interactions, strand-pairing, arrangement of strands into sheets, helix packing, radius of 
gyration, Cβ density which is related to solvation, steric repulsion, preferred torsions in 
the Ramachandran map, Lennard-Jones interactions, hydrogen-bonding, solvation, 
electrostatic and disulfide interactions of various residues, energies of different rotamer 
states, and unfolded state reference energy.  Details on these terms in Rosetta can be 
found in the cited references. We used Mini-Rosetta 3.3 downloaded from 
rosettacommons.org 
DFIRE and dDFIRE: DFIRE potential stands for Distance-scaled Finite-Ideal gas 






between pairs of atom types in known protein structures. The atom types are residue 
specific which resulted in a total of 167 atom types. The pair energy is calculated using 













  , 𝑟 < 𝑟𝑐𝑢𝑡
0,                                                                            𝑟 ≥ 𝑟𝑐𝑢𝑡
 
Eq. 11  
 
in which R is the gas constant, T is temperature (300 K), α equals 1.61, Nobs(i,j,r) is the 
number of (i,j) pairs within the sphere with radius r observed in the structure database, rcut 
is 14.5 Ȧ, and ∆r (∆rcut) is the bin width at r (rcut). 
dDFIRE potential stands for dipolar DFIRE. The difference between DFIRE and dDFIRE 
is that the latter takes the angles between interacting dipoles into consideration thus 
accounting for dipole-dipole interactions. 





GOAP: A plane is associated with each heavy atom defined by the heavy atom and its 
two neighbor bonded heavy atom. A local coordinate system (𝜗𝑥, 𝜗𝑦, 𝜗𝑧) is defined based 






coordinate system (for details look at the cited reference).The GOAP potential, then, is 
defined as follows: 
 
 𝐸(𝑟𝑎𝑏, 𝜃𝑎, 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) = −𝑅𝑇 
𝑃𝑜𝑏𝑠(𝑟𝑎𝑏, 𝜃𝑎, 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒)
𝑃𝑒𝑥𝑝(𝑟𝑎𝑏, 𝜃𝑎, 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒)
 Eq. 12  
 
where a and b represent atom types of the two interacting partners, rab is the distance, 
𝑃𝑒𝑥𝑝(𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) is the probability observed in the reference state and 
𝑃𝑜𝑏𝑠(𝑟𝑎𝑏 , 𝜃𝑎 , 𝜓𝑎 , 𝜃𝑏 , 𝜓𝑏 , 𝜒) is the probability observed in known protein structures. It 
should be noted that GOAP benefits from the DFIRE reference state and uses different 
equations for indifferent cut-offs. For details please refer to the cited reference. 
3.2.8 Decoy Sets 
Three different decoy sets from Decoys ‘R’ Us version 1.3 (dd.compbio.washington.edu) 
61 were used to test the performance of the various scoring functions for differentiating 
native protein structures from decoys. These decoy sets differ by the type of proteins and 
the method employed to generate the decoys. The details of these decoy sets are as 
follows. 
hg_structural: This set contains decoys for 29 globin proteins. For each protein, 
comparative modeling with all other globins in the set was performed to generate decoys 
for each of the proteins; hence each globin set contains 28 decoy structures in addition to 
the native structure. All structures were energy minimized using ENCAD  22.   
vhp_mcmd: This set focuses on the thermostable domain of villin (1vii). 6255 structures 






decoy sets and one of them which is based on the X-ray structure generating native-like 
structures. The decoy trajectories were generated starting from conformations obtained 
from a coarse-grained MC simulation.  All the structures were energy minimized with 
MM/GBSA using CHARMM. The set contains 1251 native and 5004 decoy structures. 
fisa: This set is generated from four small alpha-helical proteins (1fc2, 1hdd-C, 2cro, and 
4icb). The main chains for the decoys were modeled by fragment-insertion simulated 
annealing and Bayesian scoring functions based on fragments from proteins with similar 
local sequences. Then the SCWRL software package was used to model the side 
chains.  All the structures were energy minimized using CHARMM22b. 500 decoys for 
each of these four proteins were generated (a single file ackcalb11-min.pdb related to 
4icb was missing so one of the sets has 499 decoys). 
Considering the differences between these decoy sets, different strategies were used to 
calculate the area under the curve (AUC) in their corresponding scoring experiments (see 
section 3.2). Unlike vhp_mcmd which has only one sub-set (1vii), hg_structural and fisa 
have 29 and 4 sub-sets respectively with only one native structure in each sub-set. Hence, 
while the number of native structures found was used for calculating the AUC for 
vhp_mcmd, we used the number of sub-sets with identified native structure to calculate 
the AUCs for fisa and hg_structural. For hg_structural, identification of a structure with 
RMSD less than 2 Å with the native structure was considered equivalent to identification 









Figure 8  A) ABC triplet (AB,BC) with center B (yellow) and BAC triplet  (BA, AC) 
with center A(red). Each triplet is defined with a center and two other points, hence it 
comprises two distances. Changing the point considered as the center will lead to a a 
different triplet as the new triplet would have one common and one different distance 
compared to the previous triplet. B): Three distances observed in a triplet: AB (green), 
BC (yellow), and AC (red). By choosing a center, there will be only two distances in 






3.3 Results and Discussions 
Scoring functions are named based on prefixes and suffixes introduced in the Materials 
and Methods section. For a brief description of the scoring functions please refer to Table 
4. 
3.3.1 Quasi-three-body pseudo-potentials 
We first wanted to investigate if the presence of a third interaction site or body C does 
have any effects on the pairwise interaction of two other bodies A and B. If such an 
influence is not present, then ABi (AB pair having distance corresponding to bin i) and 
BCj (BC pair having distance corresponding to bin j) would be independent variables for 
all bins i, j. In such a case a cut of (𝑃𝑖𝑗
𝐴𝐵𝐶) along a specific j, would generate a contour 
that reproduces the pattern of probability density (𝑃𝑖
𝐴𝐵) multiplied (or scaled) by the 
value of 𝑃𝑗
𝐵𝐶  for that specific bin j, i.e. 𝑃𝑖𝑗
𝐴𝐵𝐶 = 𝑃𝑗
𝐵𝐶 ∙ 𝑃𝑖
𝐴𝐵. If C has no influence on the 
interaction profile of AB, this similarity in contour should be observed for any i, j. 
Therefore multiple contours of (𝑃𝑖𝑗
𝐴𝐵𝐶) for different j should have the same pattern with 
different scaling factors. This pattern should also match that of the corresponding 
pairwise interactions. However, observing different patterns in the contour maps and 
those also which differ from the corresponding pairwise pattern, would mean that the 
(𝑃𝑖
𝐴𝐵) distribution is influenced by j (BC distance) which implies a statistical dependency 
of ABi and BCj. Dependency between ABi and BCj means that there is higher order 
information in (𝑃𝑖𝑗
𝐴𝐵𝐶) not implied in either (𝑃𝑖
𝐴𝐵) or (𝑃𝑗
𝐵𝐶) which could be used in 






Using the abovementioned strategy, we can visualize the existence of any dependency 
between ABi and BCj in (𝐵𝑖𝑗
𝐴𝐵𝐶). (𝐵𝑖𝑗
𝐴𝐵𝐶) and (𝐵𝑖
𝐴𝐵) are calculated based on (𝑃𝑖𝑗
𝐴𝐵𝐶) and 
(𝑃𝑖
𝐴𝐵) using Eq. 6 and 7 respectively as described in detail in Materials and Methods and 
are the statistical potentials used in our scoring functions (see Eq. 8 and 9).  Figures 9 and 
10 are graphs of (𝐵𝑖𝑗
𝐴𝐵𝐶) and (𝐵𝑖
𝐴𝐵) for a number of representative triplets ((𝐵𝑖𝑗
𝐴𝐵𝐶) 
graphs for all of the triplets can be found in figure 12). The examples of (𝐵𝑖𝑗
𝐴𝐵𝐶) shown in 
figure 9 represent the effects of the presence of a third body on the potential of interaction 
between hydrogen-bond donors (D) and acceptors (A) and the (𝐵𝑖𝑗
𝐴𝐵𝐶) shown in figure 10 
represent such effects on interactions between two hydrophobic (H) elements. The 
contours of each three-dimensional plot are also shown on each side of the graph. The 
(𝐵𝑖
𝐴𝐵) corresponding to pairwise interactions is shown with the red line overlaid on the 
contours on each side of the graph. For HHX potentials (X referring to the third 
physicochemical elements) we see very high positive peaks at distances less than 3.5 Å 
(see figure 12) which can be attributed to van der Waals clashes. These peaks overwhelm 
the scaling of the rest of the graph which makes observation of discernible patterns 
difficult. In order to examine the pattern of contours in HHX potentials, the first 8 bins 
were ignored. The trimmed potentials were then re-plotted (figure 10). It is noteworthy 
that the potential from the beginning bins (~2.5-3.5 Å) dominates the whole potential for 
nearly all of the triplets. 
Despite small fluctuations the (𝐵𝑖𝑗
𝐴𝐵𝐶) graphs in figures 9 and 10 have contours that 
generally follow the same pattern. Also the pattern of contours is the same as the pairwise 







𝐴𝐵𝐶) and shows the potentials have not been highly influenced by introducing the third 
interacting body. Lack of higher order information observed in the ADX triplets could be 
related to the fact that the AD interactions are dominated by backbone-backbone 
interactions leading to the formation of secondary structure elements of the protein, thus 
they are less susceptible to the presence of a third interacting body. 
In addition to visual comparison of patterns in the quasi-three body and two-body 
distance-dependent statistical potentials, we aimed to quantify the lack of difference 
between those patterns. Using the underlying quasi-three body and two-body probability 
distribution functions, we performed Kolmogorov-Smirnov tests (K-S tests). K-S test 
compares a test sample with a reference sample and identifies if they originate from the 
same probability distribution. In our study, the null hypothesis to be tested states that the 
two samples, i.e. the pair-wise distribution functions and the corresponding slices of the 
quasi-three body function, originate from the same probability distribution. The null 
hypothesis is tested against a certain significance level where a typical value of 0.05 is 
used in this study 64,65 
 
In detail, all two-body contours (?̂?𝑖
𝐴𝐵) and (?̂?𝑗
𝐴𝐵) were obtained from bins 4 to 32 for 
each three-body probability distribution 𝑃𝑖𝑗
𝐴𝐵𝐶. Each of the contours was normalized. The 
contours were tested against their corresponding two-body distributions (𝑃𝑖
𝐴𝐵) and (𝑃𝑗
𝐵𝐶) 
obtained from an analysis of the same protein database. The first three bins were 
excluded from the analysis since they cover distances between 2.0 and 2.75 Ȧ for which 
typically only few if any observations were made in the database. For each triplet, there 






embedded within a triplet. Out of 126 triplets, only 9 triplets violate the null hypothesis in 
more than 10% of the comparisons and only two triplets in more than 20% of the 
comparisons (Table 5). 77 triplets do not violate the null hypothesis at all, i.e. the 
probability distributions of quasi-three body interactions are identical to the 
corresponding pair-wise interactions for all slices with a significance level of 0.05. The 
results show that higher order information is not established for almost 93% of all 
triplets. All of the triplets that violate the null hypothesis in more than 10% of all 
comparisons (Table 5) contain positive-negative (PN) or negative-only interactions 
(NNN). Whereas these results may be interpreted as engagement of charged atoms in 
higher order interactions, it should be noted that interaction triplets containing two 
charged atoms are relatively rare compared to all other triplets studied, and that the small 
sample size of those triplets might at least contribute to the relatively frequent violation 
of the null hypothesis. 
Figure 11 shows the statistical potential for triplet APN that displays the most significant 
higher order interactions based on the KS-test. The shallow maximum in the region 
AP=3.0-5.0 and PN=5.0-8.0 might represent an instance of higher order interactions in 
this potential map.  
3.3.2 Quasi-three-body scoring functions 
KS-test analysis demonstrated that there are only a few three-body potentials with 
significant higher order interactions. Consequently, a significant improvement in scoring 
performance is not expected between quasi- three-body distance-dependent potentials and 
their two body counterparts. The following study was designed to support this argument 






not the influence of a third body on the interaction profile between two particles would 
improve the performance of the potential in its ability to discriminate native-like 
structures from decoy structures. The graphs resulted from using various scoring 
functions tested for vhp_mcmd, hg_structural and fisa decoy sets can be found in 
Supplementary Material (figures 13, 14 and 15). The area under the curve (AUC) 
(ranging 0 to 1) of these graphs are plotted in figure 16 and can be used for comparison 
between different scoring functions.  
In general the scoring functions developed in this study are very successful in identifying 
native structures from decoys. Our scoring functions perform perfectly on the fisa decoy 
set displaying highest AUC (equal to the ideal scoring function). Also these scoring 
functions have very good performances which are comparable to or better than the 
conventional scoring functions for vhp_mcmd and hg_structural decoys sets. This 
observation is important as it supports our idea of using protein structure prediction as a 
practical test case for comparing quasi-three body and pairwise atomistic statistical 
potentials. Although Ca_2b_score and Ca_3b_scores are not as successful as the rest of 
our pairwise and three body scoring function for two of the decoy sets, it is hard to 
identify one representation of the interacting bodies which always leads to superior 
performance. Also there is not a significant difference between scoring performance of 
smthd_Phys_score and Phys_score and they almost overlap. Simple counting methods 
have good performances in fisa and show better or comparable results compared to 
conventional scoring functions. 
The general linear correlation in figure 16-A implies similar scoring performances of 






not observe a significant improvement or deterioration in scoring performance by 
switching between pairwise and three-body functions.  
Examples of approximate time needed for calculations of two main steps for pairwise and 
quasi-three body scores are shown in table 6. The first step is populating (𝐶𝑖𝑗
𝐴𝐵𝐶) or 
(𝐶𝑖𝑗
𝐴𝐵) and normalizing them with distance squared (d2). The second step is multiplication 
of distance-normalized (𝐶𝑖𝑗
𝐴𝐵𝐶) by (𝐵𝑖𝑗
𝐴𝐵𝐶)  to calculate 𝑆𝐴𝐵𝐶 and 𝑆𝐴𝐵 (equations 8 and 9). 
Although pairwise scoring takes less time, quasi-three-body scoring is still extremely 
fast. For instance, the total time needed for qusi-three-body scoring of the largest protein 
tested (153 amino acids) is less than 4 sec. 
3.3.3 Correlations between different scoring functions 
In order to investigate potential correlations between the various scoring functions tested 
in this study, we calculated the Pearson correlation coefficient between scores obtained 
from the various scoring functions for each subset in all decoy sets. Specifically, a high 
correlation between two-body and quasi-three-body scores can be additional evidence for 
the lack of higher order information in quasi-three-body potentials. Figure 17 graphically 
shows correlations for selected subsets of various decoy sets. The correlation heat maps 
for all subsets of all decoy sets can be found in the Supplementary Material (Figure 18). 
Figure 17 shows correlation between the scoring functions for the vhp_mcmd decoy set 
(represented by 1vii). In general, all of the corresponding two-body and quasi-three-body 
scoring functions show very high correlations (> 0.8) with each other. Excluding the 
Ca_3b_score and Ca_2b_score scoring functions, the remainder of the two-body and 






(dDFIRE, DFIRE2, GOAP, Rosetta, FoldX) are highly correlated (>0.7 with DFIRE2, 
dDFIRE, FoldX, and >0.6 with Rosetta, GOAP). Correlation coefficients between 
various scoring functions for the hg_structural decoy set (as represented by 2pgh-A 
subset in figure 17) follow the same general pattern as the vhp_mcmd.  We again see 
high correlations (>0.8) between two-body and quasi-three-body scores in this decoy set.  
There is much less correlation among the physicochemical element-based statistical 
scoring functions, dDFIRE, DFIRE2, GOAP, FoldX and Rosetta for the fisa decoy set. 
Similar to vhp_mcmd and hg_structural decoy sets scores based on Cα's are weakly 
correlated with our other scores (figure 17) although they are highly correlated with each 
other (>0.7). The high correlation (>0.6) between two-body and quasi-three-body scores 






Figure 9 Graphs of (𝐵𝑖𝑗
𝐴𝐵𝐶) (quasi-three-body statistical potential for interacting triplet ABC 
with distance bins i and j) of a number of representative triplets (indicated by the three letter 
code on top of each graph). Only interactions with pairwise distances between 2 to 10 Å are 
considered. The contours of each plot (darker colors for bins with larger distances) are shown 
on each side of the graph. The corresponding (𝐵𝑖
𝐴𝐵) (two-body pseudo-statistical potential for 
interacting pair AB with distance bins i) is shown by a red line overlaid onto the contours. 
These quasi-three-body pseudo-potentials show the effects of the presence of a third body on 









Figure 10 Graphs of (𝐵𝑖𝑗
𝐴𝐵𝐶) (quasi-three-body statistical potential for interacting triplet 
ABC with distance bins i and j) of a number of representative triplets (indicated by the 
three letter code on top of each graph). Only interactions with pairwise distances between 
2 to 10 Å are considered. The contours of each plot (darker colors for bins with larger 
distances) are shown on each side of the graph. The corresponding (𝐵𝑖
𝐴𝐵) (two-body 
pseudo-statistical potential for interacting pair AB with distance bins i) is shown by a red 
line overlaid onto the contours. These quasi-three-body pseudo-potentials show the effects 


























Figure 11 Graph of (𝐵𝑖𝑗
𝐴𝑃𝑁) (quasi-three-body statistical potential for interacting triplet 
APN with distance bins i and j). Only interactions with pairwise distances between 2 to 
10 Å are considered. The contours of the plot (darker colors for bins with larger 
distances) are shown on each side of the graph. The corresponding (𝐵𝑖
𝐴𝑃) and (𝐵𝑖
𝑃𝑁) 
(two-body pseudo-statistical potential for interacting pair AP and PN respectively with 
distance bins i) is shown by a red line overlaid onto the contours. APN shows the most 






Figure 12 Graphs of (𝐵𝑖𝑗
𝐴𝐵𝐶) of a number of representative triplets (indicated by the three 
letter code on top of each graph). Only interactions with pairwise distances between 2 to 
10 A are considered. The contours of each plot (darker colors for bins with larger 
distances) are shown on each side of the graph. The corresponding (𝐵𝑖
𝐴𝐵) (two-body 
pseudo-statistical potential for interacting pair AB with distance bins i) is shown by red 





































































































































Figure 13 Number of sub-sets in vhp_mcmd decoy set that their native structure is ranked 
among various top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta, 













Figure 14 Number of native structures in hg_structural decoy set ranked among various 
top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta, B) two-body and 














Figure 15 Number of sub-sets in fisa decoy set that their native structure is ranked in 
among various top percentages of structures, by A) dDFIRE, DFIRE2, FoldX, Rosetta, 













Figure 16 A) AUCs resulted from quasi-three-body scores vs AUCs of their two-body 
scores in different decoy sets tested. Comparison of pairwise to quasi-three body scoring 
functions shows little differences in structure-prediction quality. B) AUCs resulted from 
conventional scoring functions and simple counting methods. Result for vhp_mcmd, fisa, 
















































































































Figure 18 : Pearson correlation coefficient among 1- Phys_2b_score 2-  Phys_3b_score 
3- Amb_2b_score 4- Amb_3b_score 5- CALPHA_2b_score 6- CALPHA_3b_score 7- 
FoldX 8- Rosetta 9- dDFIRE 10- DFIRE2. The title of each graph shows ‘decoy set : 

















































Calculating the free energy of a protein system using statistical potential derived from 
pair-distribution functions is not physically justified. Theoretically, for using statistical 
potentials to compute the total free energy of a protein system, the energies should be 
expressed in terms of multi-body interaction terms. Various multi-body potentials have 
been developed based on this theoretical argument. Higher order information and better 
scoring performances are reported for those multi-body potentials57,66–68. To the best of 
our knowledge, however, all of those multi-body potentials are based on a coarse-grained 
representation of interacting bodies and are contact-based. In this study, we asked the 
question if higher order information is also important for distance-dependent statistical 
potentials that are based on an atomistic representation of the interacting bodies.  
Our results indicate that the multi-body interaction energies are dominated by pairwise 
interactions, with small contributions from higher order interactions, resulting in the lack 
of significant difference between pairwise and quasi-three-body potentials. In contrast to 
our initial hypothesis, we have seen in the majority of cases a lack of distance 
dependency between two pairs of interacting bodies constituting quasi-three-body 
statistical potentials. Higher order interactions can only be established in few triplets 
modeling interactions between charged atoms. In other words, besides charge 
interactions, considering the effect of the distance of a third interacting body on the pair 
distribution function of two other interacting bodies utilizing the methods we presented in 
this study adds negligible additional information to the statistical potential. Considering 
scarcity of charged bodies in protein structures compared to other types of interacting 






This similar performance can be attributed to the lack or weakness of such higher order 
information in quasi-three-body potentials. We see a very high correlation between 
corresponding quasi-three-body and two-body scores which is in line with similarities in 
the patterns of contour maps observed in quasi-three-body and two-body potentials. 
The scoring functions developed in this study show higher or comparable performances 
with the four conventional scoring functions tested. We also obtain good results for many 
systems from simple counting scoring functions designed to model hydrophobic or 
hydrogen bond interactions. High performance of these simple counting approaches can 
be attributed to the decoy sets not being sufficiently challenging. Also it can imply that 
hydrogen bonding and hydrophobic effect can adequately be used to differentiate native 
structures from decoys in many protein systems. It is not surprising considering the 






Table 4 Brief description of the scoring functions generated throughout the study. 
Score Title  Description 
count_Ca_score Number of Cα’s within 5 Ȧ distance of each other 
count_Phob_score Number of hydrophobic atoms within 5 Ȧ distance of each other 
count_H_score Number of hydrogen bonds formed 
Phys_2b_score Two-body score based on physicochemical elements 
Phys_3b_score Quasi-three-body score based on physicochemical elements 
smthd_Phys_2b_score Phys_2b smoothed by a cubic spline 
smthd_Phys_3b_score Phys_3b smoothed by a cubic spline 
Amb_2b_score Two-body score based on AMBER atom types 
Amb_3b_score Quasi-three-body score based on AMBER atom types 
Ca_2b_score Two-body score based on Cα atoms 




















Table 5 Triplets with more than 10% violations of null hypothesis in KS-test: Normalized 
contours of quasi-three-body joint probability distributions are compared with the 
corresponding two-body probability distribution using KS-test. Out of 126 triplets, nine 
triplets violate null hypothesis that distributions are the same for more than 10% of all 
distance slices. 
Triplet Number of violations of null hypothesis with significance 




























Table 6 Examples of time needed for calculations of main steps of quasi-three-body and 
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Populating 
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vhp_mcmd 36 0.124 0.002 0.001 0 
2cro fisa 65 0.399 0.005 0.001 0 
1emy hg_structura
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CHAPTER 4. FIBPREDICTOR: A COMPUTATIONAL METHOD FOR RAPID 
PREDICTION OF AMYLOID -FIBRIL STRUCTURES 
4.1 Introduction 
In this chapter, a computationally fast and general computational procedure, FibPredictor, 
is proposed to generate structural models for any amyloid fibril, starting from its 
sequence. Despite the efficiency of the algorithm, the generated models are accurate in 
generating experimental structures among the top-5 ranked models, for providing a 
description of the structural landscape available to an amyloid fibril forming sequence 
and can be used as initial structures for more sophisticated computational studies. 
FibPredictor is available at http://nanohub.org/resources/fibpredictor. 
The following two-step procedure of Fibpredictor was developed to generate amyloid 
fibril structures: For a given protein sequence, an ensemble of candidate amyloid fibril 
structures is generated comprehensively representing the amyloid fibril conformational 
space accessible to that specific sequence. This ensemble contains representative 
structures from all eight classes of amyloid fibrils. These eight classes are described in 
table 7 and figure 19. Further details can be sought at the cited references 16,30. Using a 
scoring function developed for protein-structure prediction, the most energetically 
favorable candidate structures are then identified comprising the suggested computational 






None of the individual steps of this computational procedure includes time consuming 
and computationally expensive methods, such as molecular dynamics simulations, so the 
procedure is computationally efficient and easy to implement. Validity of the approach is 
demonstrated by reproducing the experimentally determined structures of six amyloid 
fibrils. 
4.2 Materials and Methods 
4.2.1 Input for Fibpredictor 
The minimum necessary input for the program Fibpredictor are the sequences of all 
strands within each of the interacting β-spines. β-spines are β-sheets which interact with 
each other side-by-side to form the full amyloid fibril. The sequences of each individual 
strand within each β-spine can be identical or different, covering various cases of amyloid 
fibrillation. The number of β-strands and their length should be the same for both β-
spines. 
4.2.2 Generating the structural ensemble 
Figure 20 summarizes the procedure for generating the structural ensemble of amyloid 
fibrils. First, coordinates of the backbone atoms (Cα, C, O and N) are generated for one 
of the β-spines as a regular β-sheet. These strands should have the same number of 
residues. Two separate sets of coordinates are generated, one as a parallel and the other as 
an anti-parallel β-sheet. For each set of coordinates, the normal vector of the approximate 
sheet formed by all Cα’s is determined. This normal vector is calculated by averaging 
over normal vectors of all planes formed by any three Cα’s. This vector is then tilted and 
elongated randomly within a user-defined range of values for tilt angles and elongation 






backbone of the second β-spine. The ranges for tilt angles and elongation lengths in the 
current study were set to 45 degrees and 3.5 - 14 Å, respectively, but can be adjusted by 
the user to the target amyloid fibril specifications. Note that in order to adjust these 
specifications, no knowledge about the details of the structure of the target amyloid fibril 
is necessary. Instead, the length of the side chains in their fully extended conformations 
can be used to set the maximum distance between the sheets. The length of the fully 
retracted conformations of the side chains, on the other hand, can be used to set the 
minimum distance between the sheets. Initial hypotheses on the probable types of 
interactions between certain amino acids on the first and the second sheet can be used to 
limit the range of the tilting angles. 
Multiple translation vectors are randomly generated to create structural options for the 
second β-spine relative to the first β-spine. It is necessary to sample relative positions for 
the two β-spines which can lead to proper entanglement of the side-chains, creating a 
strongly interacting steric zipper. Fifty translation vectors were used for this study.  For 
each of these translation vectors, the backbone atom coordinates of the first β-spine are 
copied along the translation vector to generate the backbone coordinates of the second β-
spine. In addition to simple copying of the coordinates, rotation operations are performed 
on the second -spine to generate other members of the eight potential classes of amyloid 
fibrils.  Rotation around the z-axis generates similar or different directionalities of the -
spine (classes two, three, six and eight) and rotation around the x-axis generates face-to-
face or face-to-back steric zippers (classes one, three, five and eight). In summary, the 
different copies of the second -spine are generated by simple copying or by additional x-






classes for each of the initial parallel and anti-parallel backbone coordinates comprising 
all eight classes of amyloid fibrils. Table 7 shows the initial β-sheet conformations and 
rotations used to generate each of the eight classes. 
Each of these initial backbone structures is then passed to the side-chain prediction 
program SCRWRL4 which adds all sidechains to the backbone using a rotamer library 
aiming to minimize the SCWRL4 scoring function 70. 
4.2.3 Scoring the ensemble structures 
We tested three different scoring functions to identify the most energetically favorable 
candidate structures in the ensemble: GOAP, Amb_3b, and the SCWRL4 internal scoring 
function. The SCWRL4 internal scoring function is used by SCWRL4 to predict the 
energetically lowest side chain orientations 70. SCRWL4 uses a rotamer library and 
calculates the self-free energy and the pair-wise free energy of the different rotamers 
using a scoring function including terms describing intra- and intermolecular interactions 
such as hydrogen bonding and van der Waals interactions. For more details the reader is 
referred to 70. 
 GOAP71, is a statistical scoring function widely used in homology modelling, especially 
as part of the homology-modelling software MODELLER72. GOAP defines a plane with 
each heavy atom and two other neighboring bonded heavy atom and associates a local 
coordinate system (𝜗𝑥, 𝜗𝑦, 𝜗𝑧) with this plane. Two polar angles ψ and θ  and a torsional 
angle χ are then defined using this coordinate system. The GOAP potential, then, is 
calculated as shown in Eq. 12. 
Amb_3b is a statistical  scoring function developed in our lab, which has shown better 






FoldX in differentiating native from decoy protein structures in three different protein 
structure ensembles 73. Interacting partners are represented as AMBER atom types. The 
total energy of the protein structure is then determined using a pre-calculated quasi-three 
body statistical potential as shown below: 
 𝐴𝑚𝑏_3𝑏 =  ∑ ∑(
𝐶𝑖𝑗







 Eq. 13  
Where A, B and C represent interacting partners, ABC refers to any possible quasi-three 
body interaction, i and j refer to the discretized distance between the first and second, and 
second and third interacting partners, di and dj represent the interaction distances in 
angstroms, 𝐶𝑖𝑗
𝐴𝐵𝐶 is the frequency of each triplet ABC in the distance interval 
corresponding to i and j and  𝐵𝑖𝑗
𝐴𝐵𝐶 is the pre-calculated quasi-three body potential for 
ABC interaction in distance i and j. 
4.2.4 FibPredictor usage and GUI 
A graphical user interface (GUI) was developed for FibPredictor (Figure 21) allowing the 
user to specify the options of the software and export the results. For complete details on 
usage the reader is referred to user’s manual available on 
https://nanohub.org/resources/fibpredictor/supportingdocs. The most important options 
are described in more detail in the following. 
4.2.4.1 Sequences of the first and the second sheets:  
FibPredictor models amyloid fibrils as two β-sheets parallel or antiparallel to each other. 






strands of the first (top box) and the second (bottom box) β-sheet in one-letter amino-acid 
code.   
4.2.4.2 Sense of the β-sheets: 
Amyloid fibrils can be formed by parallel or anti parallel β-sheets. FibPredictor can 
generate both types of backbone structure for amyloid fibrils, but the user can limit the 
modelling to only one types if experimental data on the sense of the target amyloid fibril 
does exist. 
4.2.4.3 Scoring function: 
Either the Amb_3b or GOAP scoring function, or both, can be chosen for ranking the 
ensemble of generated amyloid fibril models. The SCWRL4 internal scoring function is 
always used internally in FibPredictor as part of the side-chain optimization using 
SCWRL. Amb_3b is computationally more efficient than GOAP and can be used for 
initial modeling studies. A consensus scoring scheme using all of the three available 
scoring functions may allow for the most robust ranking of the structure models. 
4.2.4.4 Rotations: 
Rotations of one β-sheet with respect to the other are used to generate the various classes 
of amyloid fibrils. All types of rotations should be chosen unless experimental data allow 
some amyloid classes to be eliminated. 
4.2.4.5 Number of randomly generated models (Rand. models): 
This variable specifies the number of translation vectors generated to place the second 






With increasing number of random vectors, the chance of obtaining good models 
increases at the cost of reduced computational efficiency. 
4.2.4.6 Top models: 
This variable determines the number of top-ranked structures provided as output to the 
user, based on the selected scoring function. This output allows the user to perform a 
more focused analysis of the predicted amyloid fibril models. 
4.2.4.7 Minimum distance between the sheets:  
This variable specifies the minimum distance between the sheets and should provide 
enough space between the sheets to accommodate side chains in the steric zipper 
conformation in a fully entangled conformation (Figure 20 and Figure 22-A). 
4.2.4.8 Distance variation between the sheets: 
This variable specifies the variation between minimum and maximum distance of the two 
sheets when generating the amyloid fibril structure models. The distance separation for 
each model will be a random number within this range (Figure 20 and Figure 22-A). 
4.2.4.9 Angle variation between the sheets: 
This parameter specifies the maximum horizontal translation of the second sheet with 
respect to the first sheet for investigating different entanglements of sidechains between 
the sheets (Figure 20 and Figure 22-B). 
4.2.5 Validation 
In order to demonstrate the ability of Fibpredictor to correctly model amyloid β-fibrils, 







corresponding PDB-IDs of the six structures are 3OVL (class1)74, 3HYD (class 1), 
2ONV (class 4), 3OW9 (5), 2OMQ (class 7) and 2ONA (class 8) 16. Despite the 
increasing number of amyloid fibril structures deposited in the protein data bank, only a 
small fraction are suitable for validating our structure prediction method because many of 
the deposited structure lack either the β-sheet or the steric zipper portion of amyloid 
fibrils.  
Using an in-house program based on BioPython, all computational models generated for 
each of these six systems were superimposed on their corresponding reference PDB 
structure and their root mean square deviation (RMSD) from the experimental structure 











Figure 19 Eight classes of amyloid fibrils. Molecular models do not represent any natural 
fibril and are only presented to highlight the different classes. For more details refer to 


















Figure 20 Procedure for generating computational candidate models for 
amyloid structures (example PDB ID: 2ONA). Multiple translation vectors are 
generated randomly and for each candidate structure four separate structures 
































Figure 22 Minimum distance, distance variation (A) and angle variation (B) parameters 
in FibPredictor. The green schematic represent the initial β-sheet. The blue schematics 












4.3 Results and discussion 
Figure 23 shows the modelled structures with the lowest RMSD, superimposed on their 
reference PDB X-ray crystal structures. For all of the six amyloid fibril test systems, 
FibPredictor generates structures with an RMSD less than 2.5 Å from the reference PDB 
structure. This demonstrates the feasibility of the computational sampling procedure to 
generate ensembles which contain fibril structures very close to the experimentally 
observed structure. 
In order to investigate the accuracy of the three tested scoring functions for identifying 
the native fibril structures in the generated ensembles, an enrichment analysis was 
performed. For each protein system, the ensemble structures belonging to the class of the 
amyloid reference structure were ranked according to the three different scoring 
functions. The percentage of near-experimental structures (RMSD <3 Å) identified as a 
function of scoring rank of all predicted structures was plotted in the enrichment graphs 
shown in Figure 24; the underlying scatter plots are shown in Figure 25. The performance 
of an ideal scoring function and that generated by a random ranking of the structures are 
also shown for comparison. We observe that the results of the scoring functions usually 
are significantly better than random selection and sometimes even approach the ideal 
enrichment. This means that the scoring functions are generally successful in identifying 
the correct fibril structures. Overall, GOAP is the most successful scoring function in 
four of the test systems and Amb_3b is the best scoring function for the other two fibril 
systems. Within the correct class of amyloid fibril, the first native-like model is identified 
among the top 5 ranked structures with both GOAP (3OVL, 3HYD, 2ONV, 3OW9, 







amyloid fibrils, the first native-like model appears among the top 10 structures for both 
GOAP and Amb_3b. 
Although the scoring functions were successful in enriching native-like structures among 
the top-ranked structures within one class, they failed to differentiate between classes. 
Figure 26, for example, displays GOAP scores as a function of RMSD for the 2OMQ 
system. The graphs of the other scores and amyloid fibril systems follow the same 
general pattern (Figure 25). Although there are small differences between various classes, 
there are always predicted structures with favorable scores which belong to classes other 
than that of the reference structure and thus have high RMSD. This, however, does not 
necessarily mean that the scoring functions failed in identifying favorable structures, as 
structural polymorphism is widely observed in amyloid fibrils 75–77. Hence, it is likely 
that the structure represented by the reference PDB is only one of several amyloid fibril 
structures energetically accessible to the peptide sequence. Structures with favorable 
scores but high RMSD may represent other polymorphs of the β-fibril as they display 
















Figure 23 Predicted structure (carbon atoms in white) with the lowest RMSD value 
superimposed to their experimental reference PDB structure (orange) for the six fibril 








Figure 24 Enrichment plots for the four amyloid classes using three different scoring 
functions, showing the percentage of identified near-experimental fibril structures as a 
function of ranked ensemble structures. The reference PBD ID, its amyloid class, sense of 
the initial sheet (parallel (par) or anti-parallel (antipar)) and applied rotation operations 








Figure 25 Various scores vs. RMSD for all of the six amyloid systems tested. The 































































































Figure 26 GOAP score vs. RMSD for 2OMQ fibril. The triangle displays the score of the 
















In this paper, we have reported a general, computationally efficient method for structure 
prediction of amyloid fibrils. We have demonstrated that native-like amyloid fibril 
structures can be generated based on the sequence alone. Currently, due to the lack of 
knowledge about potential structural polymorphism of amyloid fibrils, it is unclear 
whether the method identifies the most energetically favorable class of amyloid fibril for 
a peptide sequence, or whether equally favorable amyloid fibril structures for the same 
sequence exist. Thus, FibPredictor results should be combined with  experimental data to 
determine the sense of the amyloid β-spine 78, to reduce the analysis to a small subset of 
fibril classes.  In such cases, FibPredictor demonstrated the ability to identify the correct 
amyloid fibril structures among the top-ranked conformations.  
The structures generated by our program can also be useful in interpreting experimental 
data, e.g., by fitting them to SAXS spectra or for interpreting residue interactions 
observed by NMR. Fibpredictor results can also be combined with more sophisticated but 
computationally demanding simulation methods to further refine the initial predicted 
structures, identify potentially important interactions in amyloid fibrils, study mechanical 
properties of amyloid fibrils79,80 and quantify the free energies of amyloid fibril stability. 
Finally, analysis of ensembles of energetically favorable structures generated by 










Table 7 Eight classes of amyloid β-fibrils 16 and the rotation operations used by 
FibPredictor to generate each amyloid class. Figure 19 presents visualization of the 
different fibril classes. 





Steric Zipper Rotation 
operation 
1 Parallel Up-up Face-to-face X 
2 Parallel Up-up Face-to-back Z 
3 Parallel Up-down Face-to-face ZX 
4 Parallel Up-down Face-to-back No rotation 
5 Anti-Parallel Up = down Face-to-face X 
6 Anti-Parallel Up = down Face-to-back Z 
7 Anti-Parallel Up-up Face = back No rotation 














CHAPTER 5. PHOSPHATE ESTER DERIVATIVES OF GLUCAGON 
5.1 Introduction 
In this chapter stable phosphorylated glucagon derivatives are introduced as glucagon 
pro-drugs which are soluble in neutral pH. Phosphate groups which can be removed upon 
administration by serum phosphatases have been successfully used in past to enhance 
small molecule and peptidomimetic drug solubility and delivery 4–6,81,82.  Also, 
phosphorylation has been shown to be able to affect fibril formation of small peptides 
5,6,83–88. Based on the idea of phosphate derivate prodrugs and phosphate-mediated 
fibrillation modulation, we designed stable and soluble phospho-glucagon prodrugs. This 
design was based on a rigorous computational analysis which suggested that 
phosphorylation at certain rationally-picked residues can effectively prevent fibrillation. 
The enhanced solubility and chemical and physical stability of these prodrugs are shown 
by various methods. Also results show the phosphate group can be removed 
enzymatically in phosphatase enzyme concentrations close to serum conditions, resulting 
in free native glucagon. 
5.2 Materials and Methods 
5.2.1 Phosphorylation Sites and Possible Phospho-glucagon Prodrugs 
There are 10 readily phosporhylatable sites on glucagon (i.e., His1, Ser2, Thr5, Thr7, 







singly phosphorylated, 45 doubly phosphorylated and 120 triply phosphorylated possible 
glucagon prodrugs carrying between one and three phosphate groups, a total of 175 
distinct molecules.  Allowing for up to ten sites of phosphorylation, the number of 
distinct phospho-glucagon derivatives increases to 1023. This study is focused on 
phospho-glucagon derivatives containing only one phosphate group, since these are the 
simplest to produce and serve to demonstrate the approach. 
5.2.2 Computational Modelling of Glucagon Fibrils 
Crystal structures of a glucagon fibril have not been resolved yet. Therefore, 
computational modeling was used to rationally identify strategies for inhibiting glucagon 
fibrillation. Small angle X-ray scattering (SAXS) 30 and Fourier transform infrared 
(FTIR) spectroscopy data of glucagon fibril structures21 were used to limit the possible 
geometries for glucagon fibrils. FTIR data21 shows that the glucagon fibril is formed by 
antiparallel β-sheets.  SAXS data shows that the glucagon fibril has a diameter of 45 Å, 
which is half of the length of a fully extended glucagon. This suggests that glucagon folds 
onto itself and is not fully extended in its fibril form. Combining the SAXS data with 
FTIR, only two different fibril classes remain possible for glucagon. Each of these classes 
can form steric zipper by entanglements of side chains on two sides of the β-sheet which 
results in four formations in total (Figure 28).  
Due to impreciseness inherent to the SAXS data, however, it is not clear how many of the 
amino acids engage in forming the steric zipper, how many form the loop and how many 
terminal residues are free and unstructured. With a loop length ranging from 3 to 17 
amino acids and allowing zero, one or two free terminal amino acids yields 64 possible 







different directions (Figure 28) doubling the number of possible formations. FibPredictor, 
a program developed in the investigators’ lab for computational modelling of steric 
zipper regions of amyloid fibrils89, was then used to generate 100 candidate structures for 
each of 128 formations, amounting to 12,800 structural models covering a comprehensive 
set of hypothetically possible structures for the geometries compatible with the SAX and 
FTIR data. Fibpredictor models the steric zipper by first placing the backbone atoms of 
the two sheets within a user defined minimum and maximum distance (and a certain 
range of tilting angles). Then the side chains are optimized for each relative position of 
the two sheets using SCWRL4 70 and the energy of the final structure model is calculated. 
Fibpredictor has two options for scoring, GOAP71 and Amb_3b73. For this study, we used 
the GOAP score to identify energetically favorable models. 
From the 128,000 steric zipper models, the top 500 most energetically favorable were 
investigated by an in-house program for the most frequent inter-residue contacts. To 
overcome the preference for larger models, the energy was normalized by the number of 
residues. A pair of residues with any two heavy atom closer than 5 Å to each other were 
considered as a contact. 
5.2.3 MD Simulations 
The model of glucagon steric zipper generated by FibPredictor with the lowest average 
energy per residue among all models (NOP) (Figure 29A) and three phosphorylated 
analogues (Figure 29B) were simulated to investigate the effect of phosphorylation on the 
stability of the steric zipper. The phosphorylated analogues represented the 
phosphorylated steric zipper in three different protonation states: doubly protonated 







SEN and S1P were simulated in pH 2.5, and SEP was simulated in pH 7.4 to reproduce 
different experimental conditions of fluorescence studies described below. The proteins 
were solvated in a pre-equilibrated octahedron of TIP3P water molecules with a 
minimum distance of 20 Å between the box boundary and any solute atom37. Simulations 
were performed using the AMBER constant pH force field 92.  
The shake algorithm was used to constrain hydrogen containing bonds 39. The 
simulations were performed in an NPT ensemble. The temperature was maintained at 298 
K with a Langevin thermostat40 with collision frequency of 1 ps-1. Isotropic position 
scaling with pressure relaxation time of 2 ps was used to maintain pressure at 1 atm. The 
electrostatic interactions in periodic boundary conditions were treated using the particle 
mesh Ewald method 38. The cut-off for van der Waals interactions was set to 10 Å. The 
integration time step was 2 fs.  
The water molecules and peptide were energy minimized first with and then without 
restraints. The system was then heated from 0 K to 298 K gradually over a 20 ps. The 
system was then equilibrated in an NPT ensemble for 100 ps. The main production MD 
runs were performed for 60 ns. 1200 snapshots were saved for each production 
simulation. Contacts were defined as two residues on the two sides of the steric zipper 
with closest distance to each other. The terminal amino acids were excluded from this 
study due to their flexibility. Initial contacts were defined as contacts that were identified 
in the initial equilibrated structure. Contacts were defined between two closest amino 
acids on the two sides of the steric zipper. The contacts were tracked over the full 







5.2.4 Peptides and their solubility 
Research  grade  human  glucagon  was  purchased  from  ProSpec  (East  Brunswick,  
NJ). Phosphorylated-glucagon derivatives were purchased from GenScript (Piscataway, 
NJ). Solubility of glucagon derivatives were reported by GenScript.  
5.2.5 Stability study (24 h) 
Glucagon, phospho-Ser2-, phospho-Thr5- and phospho-Ser8-glucagon were prepared at 
1.6 mg/mL in 3.2 mM HCl, 0.9% NaCl (w/v) (pH 2.5) and phospho-Thr5-glucagon and 
phospho-Ser8-glucagon were prepared at 1.6 mg/ml in 1X phosphate buffer saline (PBS),  
pH 7.4. Samples were centrifuged at 14,000 rpm for 5 min and filtered through 0.1 μm 
filters to remove any insoluble material. 100 μL of the filtered samples were quickly 
transferred to a 96-well black flat bottom microtiter plate in triplicate and incubated with 
50 μM ThT final concentration. The final volume was adjusted to 200 μL using the 
corresponding buffer as mentioned above. The plate was sealed with a crystal clear 
sealing tape. Fluorescence measurements were carried out in a BioTek Synergy 4 Multi-
Detection microplate reader as described below. 
5.2.6 Initial stability study (31 days) 
Phospho-Thr5- and phospho-Ser8-glucagon were prepared at 1 mg/mL in 50 mM sodium 
phosphate, pH 7.4. Samples were centrifuged at 14,000 rpm for 5 min and filtered 
through 0.1 μm filters to remove any insoluble material. 100 μL of the filtered samples 
were quickly transferred to a 96-well black flat bottom microtiter plate in triplicate and 
incubated with 50 μM ThT final concentration. The final volume was adjusted to 200 μL 
using 50 mM sodium phosphate, pH 7.4. For monitoring fibrillation under different 







were sealed with a crystal clear sealing tape and incubated at 5 ˚C, 23 ˚C and 37 ˚C. 
Fluorescence measurements were carried out at regular intervals for 31 days as described 
below. 
For turbidity measurement, 100 μL of the above filtered samples were quickly transferred 
to a 96-well crystal-clear microtiter plates in triplicate and the final volume was made up 
to 200 μL using 50 mM sodium phosphate, pH 7.4. For monitoring aggregation under 
different temperature conditions, all the samples were prepared in three separate plates. 
The plates were sealed with a crystal clear sealing tape and incubated at 5 ˚C, 23 ˚C and 
37 ˚C. Measurements were carried out as described below. 
To determine the chemical stability, 1 mL of the above filtered samples were transferred 
to 2 mL glass vials which were stored at three temperatures (5 ˚C, 23 ˚C and 37 ˚C).  
5.2.7 Satibility study (35 days) 
Phospho-Thr5- and phospho-Ser8-glucagon were prepared at 1 mg/mL in 50 mM sodium 
phosphate, pH 7.4 and 1 mg/mL in 50 mM sodium phosphate with 10-4 M EDTA, pH 7.4. 
Both with EDTA and without EDTA samples were centrifuged at 14,000 rpm for 5 min 
and filtered through 0.1 μm filters to remove any insoluble material. The samples were 
aliquoted to vials and sealed under nitrogen gas and stored away from light in room 
temperature. At regulars intervals, sample vials were taken out to for the measurements 
described below. Used sample vials were then discarded. 
For fluorescence measurements, 100 μL of the filtered samples were quickly transferred 
to a 96-well black flat bottom microtiter plate in triplicate and incubated with 50 μM ThT 
final concentration. The final volume was adjusted to 200 μL using 50 mM sodium 







50 μL of the filtered samples microtiter plate and following the same procedure as above. 
The plates were sealed with a crystal clear sealing tape. Fluorescence measurements were 
performed as described below.  
Same vials were used for turbidity measurement. 100 μL samples were quickly 
transferred to a 96-well crystal-clear microtiter plates in triplicate and the final volume 
was made up to 200 μL using 50 mM sodium phosphate, pH 7.4. Measurements were 
carried out as described below. 
5.2.8 ThT fluorescence measurements 
Fibrillation was followed by measuring the fluorescence intensity of ThT with the 
excitation and emission wavelengths set to 440 nm and 482 nm, respectively. For the 24-
hour studies, measurements were carried out at 15-min intervals for 24 h at 23°C with 5 s 
automixing before each reading. For the initial 31 day studies, measurements were 
carried out every other day for 31 days with 5 s automixing before each reading. For the 
second 35 days studies measurements were carried out every week for 31 days with 5 s 
automixing before each reading. Fluorescence signals of over 100,000 (overflow) were 
set to 100,000 for visualization purposes. 
5.2.9 Intrinsic fluorescence measurements 
The excitation and emission wavelengths were set to 295 nm and 355 nm, respectively, 
corresponding to the fluorescence of Trp25. For the 24-hour study, measurement was 
carried out for 24 h at 23°C at 15-min intervals preceded by 5 s automixing before each 
reading. For the initial 31 day study, measurement was carried out every other day for 31 
days preceded by 5 s automixing before each reading. For the second 35 day study, 







each reading. Very high fluorescence signals of over 100,000 (overflow) were set to 
100,000 for visualization purposes. 
5.2.10 Turbidity measurements 
The turbidity of the peptide solutions was measured by UV absorbance at 405 nm 
and 340 nm using a BioTek Synergy 4 Multi-Detection microplate reader (BioTek 
Instruments, Winooski, VT). UV absorbance at 280 nm and 450 nm (Eq.14) and UV 
absorbance at 280 nm and 450 nm (Eq.15) were used to calculate the aggregation index-1 
(AI1) and aggregation index-2 (AI2) respectively. Measurement was carried out every 
other day for initial 31 day stability study and every week for the second 35 stability study 
preceded by 5 s automixing before each reading. The aggregation index was calculated 
using Eq. 14 and/or Eq. 15. 
 𝐴𝐼1 = 100 × (
𝐴𝑏𝑠 450𝑛𝑚 
𝐴𝑏𝑠 280𝑛𝑚 − 𝐴𝑏𝑠 450𝑛𝑚
) Eq. 14  
 
𝐴𝐼2 = 100 × (
𝐴𝑏𝑠 340𝑛𝑚 
𝐴𝑏𝑠 280𝑛𝑚 − 𝐴𝑏𝑠 340𝑛𝑚
) 



















Figure 27: Possible conformations for glucagon fibril according to SAXS and 
FTIR data. A and B show the two classes of possible formations. Each of these 
classes can form the steric zipper also on the other side of the sheet resulting in 








Figure 28: All formations of glucagon steric zipper modelled by FibPredictor. The black 










5.3.1 Computational analysis 
An example of an energetically favorable model of the steric zipper of glucagon fibril is 
in shown in Figure 29A. The model shown has the lowest average energy per residue 
among all models. The top 10 most frequent inter-residue contacts in the top 500 most 
energetically favorable models of the steric zipper region of the glucagon fibril are shown 
in Table 8. The top three most frequent contacts, Trp25-Phe6, Val23-Phe6 and Trp25-
Gly4 are of hydrophobic nature. In addition, hydrophobic residues such as Phe6, Val23 
and Trp25 are involved in seven out of the ten most frequent contacts, which confirms the 
importance of hydrophobic interactions within the steric zipper. It is also observed that 
four residues (Ser2, Thr5, Ser8 and Tyr10) which are involved in the top-10 most 
frequent contacts can be phosphorylated. Based on this contact analysis, out hypothesis 
was that the addition of a phosphate group on these four residues will insert a charged 
and highly hydrophilic group into the core of a highly hydrophobic steric zipper, thus 
“opening” the zipper and inhibiting fibril formation.  Moreover, the charged phosphate 
groups are expected to increase the solubility of the peptide. 
5.3.2 MD Simulations of the Steric Zipper Model with and without Phosphorylation 
Figure 30 shows the percentage of the initial contacts lost over the course of the 
simulation of a model of the steric zipper (NOP) and its doubly protonated (SEN), singly 
protonated (S1P) and doubly charged (SEP) phosphorylated analogues. FibPredictor is 
designed to generate energetically favorable steric zippers and therefore, native contacts 
are supposed to contribute to fibril formation. Loss of initial contact therefore, suggest a 







over the course of simulation and the steric zipper maintains its original formation. SEN 
and S1P, which reproduce different protonation species of the phosphorylated analogues 
in pH 2.5, lose around 10% and 15% of initial contacts. It should be noted that according 
to the pKa of phosphoserine93the dominant species in pH=2.5 is the doubly protonated 
analogue and therefore, the steric zipper of phosphorylated analogues at this pH is nearly 
as stable as native glucagon. This observation is in line of fibril formation of phos-Ser8-
glucagon in pH=2.5. Nevertheless, SEP in pH=7.4 loses over 20% of its initial contacts 
suggesting that the steric zipper is less stable at this pH value. This observation is in 
agreement with the experimental results showing no fibrillation for phos-Ser8-glucagon 
at pH=7.5. 
5.3.3 Solubility  
While glucagon is not soluble in pH 7.4, two of the glucagon derivatives, phospho-Thr5- 
and phospho-Ser8-glucagon are soluble (10 mg/ml and 8 mg/ml respectively) in neutral 
pH (Table 9). The solubility values presented here are according to reports by GenScript. 
More accurate solubility measurements are underway in Dr. Elizabeth Topp’s lab. 
5.3.4 Fluorescence measurements over 24 hours 
Fluorescence measurements over 24 hours are shown in Figure 31A-D.  Interaction of 
ThT with amyloid β-fibrils results in an increase in the ThT fluorescence signal and 
allows amyloid β-fibril formation to be probed. In pH 2.5 (Figure 31A), native glucagon 
begins to fibrillate after a lag time of approximately 8 hours. Glucagon rapidly goes to 
complete fibrillation after this lag time and the ThT signal reaches a plateau after 
approximately 16 hours. The phosphorylated prodrugs also fibrillate at this pH but with a 







Thr5- and phospho-Ser8-glucagon show no fibrillation over 24 hours and the ThT signal 
remains low for the period of study. Native glucagon and phospho-Ser2-glucagon cannot 
be tested for fibrillation at pH 7.4 since they are not soluble at this pH. This demonstrates 
that while glucagon and the phosphorylated prodrugs studied fibrillate under acidic 
conditions, phospho-Thr-5- and phospho-Ser8-glucagon do not fibrillate in neutral pH 
over 24-hours. A decrease in the Trp intrinsic fluorescence signal indicates 
oligomerization of the peptide. In pH 2.5 (Figure 31C), glucagon intrinsic fluorescence 
shows a sudden decrease after a lag time of nearly 9 hours. Similar behavior is observed 
for phospho-glucagon prodrugs at pH 2.5, but with longer lag times of approximately 18 
hours (phospho-Ser8-glucagon) and 21 hours (phospho-Ser2- and phospho-Thr5-
glucagon). Nonetheless, at 7.4 (Figure 31D) phospho-Ser8- and phospho-Thr5-glucagon 
intrinsic fluorescence signals remain high with no decreasing trend, which indicates a 
lack of oligomerization for these peptides at pH 7.4. 
5.3.5 ThT fluorescence measurements over the initial 31-day stability study 
Figure. 32A-C show the results for ThT assays for 31 days.  As mentioned above, upon 
interaction of ThT with amyloid fibrils, the ThT fluorescence signal increases and allows 
identification of amyloid fibril formation. The ThT fluorescence remained low for 
samples stored at 5˚C (Figure 32A), 23˚C (Figure 32B) and 37˚C (Figure 32C) for 31 
days. This indicates lack of fibrillation in these samples over the extended time period 
and the three temperatures studied. 
5.3.6 ThT fluorescence measurements over the 35-day stability study 
Figure 33 shows the results for ThT assays for 35 days.  As mentioned above, upon 







identification of amyloid fibril formation. The ThT fluorescence remained low for 
samples stored with and without EDTA for 35 days. This indicates lack of fibrillation in 
these samples over the extended time period and the three temperatures studied. 
5.3.7 Intrinsic fluorescence measurement over the initial 31-day stability study 
Figure 34A-C show results from Trp intrinsic fluorescence measurements over 31 days. 
A decrease in the Trp intrinsic fluorescence signal indicates oligomerization of the 
peptide. No such decrease was observed in the Trp fluorescence signal for samples stored 
at 5˚C (FIG. 4A), 23˚C (FIG. 4B) and 37˚C (FIG. 4C) for 31 days. This indicates no 
oligomerization at any of the incubation temperatures over 31 days. 
5.3.8 Intrinsic fluorescence measurement over the 35-day stability study 
Figure 35A-C show results from Trp intrinsic fluorescence measurements over 35 days. 
A decrease in the Trp intrinsic fluorescence signal indicates oligomerization of the 
peptide. No such decrease was observed in the Trp fluorescence signal for samples stored 
with or without EDTA for 35 days. This indicates no oligomerization over 35 days in 
either of the formulations. 
5.3.9 Turbidity measurement over the initial 31-day stability study 
Figure 36A-C show the results of aggregation index measurements over 31 days. Proteins 
do not absorb UV light at 450 nm. Any absorbance observed in this wavelength is 
generally due the light scattering by particles resulting from aggregation, and the 
aggregation index-1 (AI-1) helps quantify this. AI-1 values remained below 5 for samples 
stored at 5˚C (Figure 36A), 23˚C (Figure 36B) and 37˚C (Figure 36C) for 31 days. This 
indicates that no significant turbidity was observed for either of the two phospho-







5.3.10 Turbidity measurement over the 35-day stability study 
Figures. 37 and 38 shows the results of AI-1 and AI-2 respectively over 35 days. Proteins 
do not absorb UV light at 450 nm and 340 nm. Any absorbance observed in these 
wavelength is generally due the light scattering by particles resulting from aggregation, 
and the aggregation indices (AI-1 and AI-2) helps quantify this. AI values remained 
below 5% for samples stored with or without EDTA for 35 days. This indicates that no 
significant turbidity was observed for either of the two phospho-glucagon peptides in any 
of the two formulations. 
5.3.11 Visual Inspection of Vials in the Second Stability Study 
FIGs 10A-D show photographs of sample of the second stability study up to 28 days. No 
turbidity or visible particles were observed in the vials of phospho-Ser8-Glucagon and 





















Figure 29: A) An example of energetically favorable steric zipper models 










Figure 30: percentage of the native contacts lost over the course of the simulation of a 
model of steric zipper (NOP) and its doubly protonated (SEN), singly protonated (S1P) 


















































































































































































































































































































































































































































































































































































































































































































































































































Figure 34: Intrinsic fluorescence assay of the initial 31-day stability study in A) 5 ͦC, B) 






















































































Figure 36: Aggregation index over 31-day initial stability study study in A) 5 ͦC, B) 23 ͦC 





















































































































Figure 39: photographs of sample of the second stability study on day A) 7, B) 14, C) 











































Computational modelling of the glucagon fibril steric zipper suggests that 
phosphorylation on Ser8 and Thr5 can effectively inhibit fibrillation by introducing an 
anionic charged group into the hydrophobic entanglements of sidechains between the two 
β-sheets. This computational prediction is verified by experiments that show phospho-
Ser8- and phospho-Thr5-glucagon are soluble and stable. Neither phospho-Thr5-
Glucagon nor phospho-Ser8-Glucagon shows fibrillation and neutral pH solution of both 
remain clear with no turbidity for more than one month. This indicates the potential of 
these molecules to be formulated as injection pen or for use in artificial pancreas devices. 
The fact that phospho-Ser2-glucagon fibrillates in both acidic and neutral pH shows that 
phosphorylation inhibits fibrillation in a site-specific way and merely hanging a charged 
group on glucagon is not enough for preventing its fibrillation. The charged group should 
be placed on the correct residue. 
Phosphate derivatization increases the net charge of glucagon and, consequently, 
increases the solubility of glucagon at neutral pH. As a result, while glucagon is not 
soluble at neutral pH and should be solubilized in acidic pH, all three of the 
phosphorylated glucagon analogues tested in this study are soluble at both acidic and 
neutral pH. 
ThT assays and intrinsic fluorescence assays over 24 hours show that phospho-Thr5-
Glucagon and phospho-Ser8-Glucagon are both stable and do not fibrillation at pH 7.4. 
Both of these molecules, however, fibrillate at pH 2.5. This observation can be explained 
by different charge states of the phosphate group in the acidic and neutral pH. MD 







clarify the effect of the charge state of the phosphate group on its fibrillation inhibition 
effects. MD simulations show that the steric zipper of phospho- glucagon is stable in 
absence of the phosphate group, and in singly and doubly protonated states in neutral pH 
simulations. The steric zipper, however, does not remain stable in acidic pH simulations 
where the phosphate group is not protonated and is doubly charged. The steric effect of 
the additional volume introduced by the phosphate group therefore, is not enough to 
destabilize the steric zipper and the electric charge of the phosphate moieties plays an 
important role in their fibrillation inhibition effects.  
 
5.5 Conclusions 
In this study phosphate-ester derivatives of glucagon were computationally designed and 
tested as soluble and stable prodrugs or active derivatives of glucagon. The 
phosphorylated glucagons showed significantly improved solubility in neutral pH 
compared to glucagon. Also, contrary to glucagon which fibrillates in few hours, the 
phosphorylated glucagons did not fibrillate and were stable for weeks.  
Our research group has applied for a patent on all phosphate ester derivatives of glucagon 











Table 8: The 10 most frequent inter-residue contacts in the 500 most energetically 































Table 9: Solubility in neutral pH 
Peptide pH 7.4 (PBS) 
Glucagon Not Soluble 
phospho-Ser2-Gluc. Not Soluble 
phospho-Thr5-Gluc. 8 mg/ml 











CHAPTER 6. CONCLUSIONS 
Two strategies were tested for stabilization of glucagon formulation and preventing its 
fibrillation, penta-peptide chaperon excipients and derivatization of glucagon itself. 
Penta-peptides were shown to delay glucagon fibrillation for a few hundred minutes. 
However, after this lag time, glucagon entered a log phase and fibrillated rapidly. This 
delay, therefore, was not enough for stable formulation of glucagon.  
Derivatization of glucagon was shown to be more effective for inhibiting glucagon 
fibrillation. Two phosphate ester derivatives of glucagon, phospho-Ser8- and phospho-
Thr5-glucagon designed in this study, were stable and stayed in solution at neutral pH for 
at least one month. Currently dephosphorization studies, chemical stability studies, cell-
based assays and animal studies are underway to test the activity of these molecules and 
their mechanism of actions and find ways to further improve their formulation. 
The phosphate ester derivatives of glucagon were designed based on a computational 
method (FibPredictor) developed as a part of this project to model the steric zipper of 
amyloid fibrils. This computational method is not limited to a specific protein and can be 
applied to generate models of steric zippers starting from any user-defined sequence. The 
generated models can be used in combination with experimental data or as input for 








Another developments in this dissertation, were a number of quasi-three body statistical 
potentials for protein structure predictions. The most successful of these potentials (Amb-
3b) has been implemented in FibPredictor. However, the application of these potentials is 
not limited to fibrils and they can be broadly used for any type of protein structure 
prediction. Moreover, the theoretical framework of these quasi-three body potentials can 
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 Quasi-three body statistical potential using functional groups; results 







 Numerous small codes for analyzing and manipulating MD simulation 
trajectories and protein structures.  
Biomolecular Simulation Packages: AMBER and GROMACS (experienced in various 
advanced biomolecular simulation techniques) 
Computer-aided molecular design (experienced in various docking, QSAR and 
molecular modeling techniques) 
Large Database Analysis: developed code for compiling, processing and statistical 
analysis of large protein databases 
Relevant Work Experience:  
Research Assistant at Lill’s lab-Purdue University; West Lafayette, IN; August 2012-
December 2015 
 Developed scientific software for modelling protein structure and interactions 
 Developed statistical force fields for protein structure prediction  
 Performed peptide virtual screening 
 Simulated and analyzed biomolecular systems 
 Developed multivariate quantitative structure activity relationship models 
 Rationally designed peptide therapeutics and excipients 
Research Assistant at Topp’s lab-Purdue University; West Lafayette, IN; August 2014- 
December 2015 
 Designed and evaluated peptides therapeutics and formulations 
 Analyzed peptide formulation stability using various spectroscopic methods 










Teaching Assistant Purdue University; West Lafayette, IN; August 2011-December 
2012 
 Organic Chemistry II Laboratory (MCMP205L), Fall 2012 
 Medicinal Chemistry and Pharmacology III: Cardiovascular & Renal 
Pharmacology (MCMP408), Spring 2012 
 Biological Chemistry I (MCMP304), Fall 2011 
Exir® Pharmaceutical Co.; Tehran, Iran; January 2010-June 2011  
 Contributed to patent document preparation 
 Evaluated bioequivalence studies for Capetopril, Cephalexin, Acetaminophen, 
Co-Amoxiclav 
 Prepared the periodic safety update report (PSUR) for Insulin 
 Contributed to idea generation sub-committee of Product Development 
Committee 
 Revised and renewed standard operating procedure for pharmacovigilence  
 Revised and renewed standard operating procedure for consumer complaint 
handling based on ISO 10002 
Medical consultant at National Drugs and Poisons Information Centre (DPIC); 
Tehran, Iran; March 2009-January 2010  








Research Assistant at Tabatabai’s lab-Shahid Beheshti Medical University; Tehran, 
Iran; January 2008- November 2010 
 Synthesized small organic molecules 
 Performed docking and molecular modelling studies 
Other Teaching Experiences 
 "Molecular Modeling and Docking Workshop"; Shahid Beheshti Medical 
University & SBMU Center for Pharmaceutical Research; December 2010, 
February 2011 and March 2011;   
Awards and Honors 
Certificate of Excellence in Interdisciplinary Research, Purdue Office of 
Interdisciplinary Graduate Programs, Spring Reception, 2014  
Distinguished Student, Shahid Beheshti Medical University, Second educational 
festival, 2006 
Ranked top student (1st place) among all pharmacy students of Iran, in the 
nationwide Basic Sciences for Pharmacy Comprehensive Exam, 2005  
 
 
 
